Package | Version | Identity | Name/Title | Status | Date | Realm | Auth | Source(s) |
---|
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2001-gestational-stage  | NZ cancer FIGO 2001 gestational trophoblastic disease stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2009-endometrial-carcinoma-stage  | NZ cancer FIGO 2009 endometrial carcinoma stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2015-corpus-uteri-adenosarcoma-stage  | NZ cancer FIGO 2015 corpus uteri adenosarcoma stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2018-cervix-uteri-stage  | NZ cancer FIGO 2018 cervix uteri stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2021-vulva-stage  | NZ cancer FIGO 2021 vulva stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-flipi-prognostic-score  | NZ cancer FLIPI prognostic score | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-follicular-lymphoma-grade  | NZ cancer follicular lymphoma grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-frozen-section-specimen-type  | NZ cancer frozen section specimen type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gastro-cancer-type  | NZ cancer gastrointestinal cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gastro-substream  | NZ cancer gastrointestinal substream | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-genitourinary-substream  | NZ cancer genitourinary substream | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-anus-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour anal topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-appendix-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour appendix topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-colorectal-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour colorectal topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-other-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour other topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-pancreas-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour pancreas topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-stomach-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour stomach topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-german-hodgkin-stage  | NZ cancer GHSG Hodgkin treatment stratification stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colon-topography  | NZ cancer gastrointestinal colon topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colorectal-topography  | NZ cancer gastrointestinal colorectal topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-duodenum-topography  | NZ cancer gastrointestinal duodenum topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-exocrine-pancreas-topography  | NZ cancer gastrointestinal exocrine pancreas topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-jejunum-ileum-topography  | NZ cancer gastrointestinal ileum and jejunum topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-liver-topography  | NZ cancer gastrointestinal liver topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-oesophagus-topography  | NZ cancer gastrointestinal oesophagus topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-pancreas-topography  | NZ cancer gastrointestinal pancreas topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-rectum-topography  | NZ cancer gastrointestinal rectum topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-stomach-topography  | NZ cancer gastrointestinal stomach topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-upper-topography  | NZ cancer upper gastrointestinal topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grade  | NZ cancer grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grading-system  | NZ cancer grading system | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haem-recurrence-type  | NZ cancer heamatology recurrence type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-stream  | NZ cancer haematology stream | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-substream  | NZ cancer haematology substream | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-treatment-intent  | NZ cancer haematology treatment intent | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-cancer-type  | NZ cancer head and neck cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-hypopharynx-topography  | NZ cancer head and neck hypopharynx topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-larynx-topography  | NZ cancer head and neck larynx topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-paranasal-topography  | NZ cancer head and neck nasal cavity and paranasal sinus topography | active | 2024-08 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-topography  | NZ cancer head and neck nasal topography | active | 2024-08 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasopharynx-topography  | NZ cancer head and neck nasopharynx topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-odontogenic-topography  | NZ cancer head and neck odontogenic topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-other-topography  | NZ cancer head and neck other topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-salivary-gland-topography  | NZ cancer head and neck major salivary gland topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-substream  | NZ cancer head and neck substream | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-with-thyroid-topography  | NZ cancer head and neck with thyroid topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-health-worker-role-path-radio-surg  | NZ cancer health worker role pathologist radiologist surgeon | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-other-topography  | NZ cancer other gastrointestinal hepatopancreaticobiliary topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-topography  | NZ cancer gastrointestinal hepatopancreaticobiliary topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-high-level-topography  | NZ cancer high level topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hl-ips-prognostic-score  | NZ cancer Hodgkin lymphoma International Prognostic Score | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ipss-r-prognostic-score  | NZ cancer IPSS-R for MDS prognostic score | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-mandatory  | NZ cancer laterality mandatory | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-optional  | NZ cancer laterality optional | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-or-side  | NZ cancer laterality or side | retired | 2024-06 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-side-mandatory  | NZ cancer laterality or side mandatory | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-with-unknown  | NZ cancer laterality with unknown value | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality  | NZ cancer laterality | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lower-gastro-cancer-type  | NZ cancer lower gastrointestinal cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lugano-lymphoma-stage  | NZ cancer Lugano staging classification for lymphoma | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lung-cancer-type  | NZ lung cancer type | retired | 2024-08 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymph-node-specimen-type  | NZ cancer lymph node specimen type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-breast  | NZ cancer breast lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-eye-orbit  | NZ cancer eye and orbit lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-cervix-uteri  | NZ cancer female genital cervix uteri lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-corpus-uteri  | NZ cancer female genital corpus uteri lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-vulva  | NZ cancer female genital vulva lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-anus  | NZ cancer gastrointestinal anus lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-colorectal  | NZ cancer gastrointestinal colorectal lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-stomach  | NZ cancer gastrointestinal stomach lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal  | NZ cancer gastrointestinal lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-head-neck  | NZ cancer head and neck lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-male-genital  | NZ cancer male genital lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax-lung  | NZ cancer thorax lung lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax  | NZ cancer thorax lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-kidney  | NZ cancer urinary and male genital kidney lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-penis  | NZ cancer urinary and male genital penis lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis-ureter  | NZ cancer urinary and male genital renal pelvis and ureter lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis  | NZ cancer urinary and male genital renal pelvis lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-testis  | NZ cancer urinary and male genital testis lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-urinary-bladder  | NZ cancer urinary and male genital urinary bladder lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital  | NZ cancer urinary and male genital lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary  | NZ cancer urinary system lymph node | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphoma-substream  | NZ cancer lymphoma substream | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-sact-cancer-type  | NZ cancer male genital SACT cancer type | retired | 2024-08 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-topography  | NZ cancer male genital topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-malt-ipi-prognostic-score  | NZ cancer MALT-IPI prognostic score | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mastocytosis-cancer-type  | NZ cancer mastocytosis cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-md-anderson-residual-cancer-burden  | NZ cancer MD Anderson residual cancer burden | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mds-myeloproliferative-cancer-type  | NZ cancer myelodysplastic-myeloproliferative cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cancer-type  | NZ cancer melanoma cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cns-topography  | NZ cancer CNS melanoma topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-menopause-status  | NZ cancer menopause status | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-non-symmetrical-topography  | NZ cancer midline non-symmetrical topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-topography  | NZ cancer midline topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipi-prognostic-score  | NZ cancer MIPI prognostic score | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipss-70-v2-prognostic-score  | NZ cancer MIPSS 70+ v2.0 myelofibrosis prognostic score | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-cns-cancer-type  | NZ cancer medical oncology cns cancer type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-cancer-type  | NZ cancer medical oncology endocrine cancer type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-neuroendocrine-cancer-type  | NZ medical oncology cancer endocrine and neuroendocrine cancer type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-genitourinary-cancer-type  | NZ cancer medical oncology genitourinary cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-gynaecological-cancer-type  | NZ cancer medical oncology gynaecological cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-cancer-type  | NZ cancer medical oncology head and neck cancer type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-cancer-type  | NZ cancer medical oncology other head and neck cancer type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-topography  | NZ cancer medical oncology head and neck other topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-male-genital-topography  | NZ cancer medical oncology male genital topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-melanoma-topography  | NZ cancer medical oncology skin and/or melanoma topography | active | 2024-09 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-topography  | NZ cancer medical oncology skin topography | active | 2024-09 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-cancer-type  | NZ cancer medical oncology solid tumour cancer type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-substream  | NZ cancer medical oncology solid tumour substream | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-cancer-type  | NZ cancer medical oncology thoracic cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-substream  | NZ cancer medicial oncology thoracic substream | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-mesothelioma-topography  | NZ cancer thorax medical oncology mesothelioma topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-topography  | NZ cancer thorax medical oncology topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-treatment-intent  | NZ cancer medical oncology treatment intent | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-testicular-topography  | NZ cancer medical oncology urinary and male genital testicular topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-topography  | NZ cancer medical oncology urinary and male genital topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-who-brain-primary-histology  | NZ medical oncology WHO brain primary histology | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-moh-refcrit-colonoscopy-2w  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-myeloid-cancer-type  | NZ cancer myeloid proliferation and myeloid neoplasm cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nail-topography  | NZ cancer nail topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nasal-paranasal-cancer-type  | NZ cancer nasal cavity and paranasal sinus cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-benign-reactive-diagnosis  | NZ cancer national cervical screening programme benign and reactive diagnosis | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-excision-completeness  | NZ cancer national cervical screening programme completeness of excision | active | 2024-09 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-specimen-type  | NZ cancer national cervical screening programme specimen type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-topography  | NZ cancer national cervical screening programme topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-response-system  | NZ cancer neoadjuvant therapy response system | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-type-non-hormone  | NZ cancer neoadjuvant therapy administration type (non-hormone) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-breast-topography  | NZ cancer neuroendocrine tumour breast topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-male-genital-topography  | NZ cancer neuroendocrine tumour male genital topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-urinary-topography  | NZ cancer neuroendocrine tumour urinary topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-gep-cancer-type  | NZ cancer neuroendocrine GEP cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-non-gep-cancer-type  | NZ cancer neuroendocrine non GEP cancer type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-substream  | NZ cancer neuroendocrine substream | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-ajcc-staging-system  | NZ cancer non-AJCC staging system | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-hodgkin-lymphoma-cancer-type  | NZ cancer non Hodgkin lymphoma cancer type | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-prostate-genitourinary-cancer-type  | NZ cancer genitourinary (non prostate) cancer type | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-not-performed-reason  | NZ cancer not performed reason | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nottingham-grade  | NZ Nottingham Combined grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nuclear-grade  | NZ cancer nuclear grade of DCIS grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-observation  | NZ cancer observation code | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-parathryoid-topography  | NZ cancer parathryoid topography | retired | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-percist-1-cancer-burden  | NZ cancer PERCIST 1.0 cancer burden | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-performance-status  | NZ cancer performance status | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pharynx-larynx-cancer-type  | NZ cancer pharynx and larynx and trachea cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pit-prognostic-score  | NZ cancer PIT prognostic score | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pituitary-net-topography  | NZ cancer pituitary neuroendocrine tumour topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-polyp-morphology-specimen-type  | NZ cancer polyp morphology specimen type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pos-neg-result  | NZ cancer positive negative result | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-presence-tumour-finding  | NZ cancer presence of tumour finding | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-procedure-status  | NZ cancer procedure status | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-prognostic-scoring-system  | NZ cancer prognostic scoring system | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-radiology-type  | NZ cancer radiology type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-rai-cll-stage  | NZ cancer Rai staging for CLL stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recist-1-1-cancer-burden  | NZ cancer RECIST 1.1 cancer burden | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recurrence-type  | NZ cancer recurrence type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-referral-criteria-procedure-assessment  | NZ cancer procedure referral criteria assessment | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-mayo-amyloidosis-stage  | NZ cancer revised Mayo staging 2012 for AL (amyloidosis) stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-multiple-myeloma-stage  | NZ cancer R-ISS for multiple myeloma stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-beam-energy-type  | NZ cancer radiation oncology beam energy type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-planning-technique  | NZ cancer radiation oncology planning technique | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-aml-disease-response  | NZ SACT acute myeloid leukemia disease response | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-amyloidosis-disease-response  | NZ SACT amyloidosis disease response | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-substream  | NZ systemtic anti-cancer therapy substream | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-type  | NZ SACT cancer type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cll-sll-disease-response  | NZ SACT chronic lymphocytic leukemia and small lymphocytic lymphoma disease response | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cml-disease-response  | NZ SACT chronic myeloid leukemia disease response | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-form  | NZ SACT dose form | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-unit  | NZ SACT dose unit | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-ecog-status  | NZ SACT ECOG status | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-haem-disease-response  | NZ SACT haematology disease response | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-heam-disease-response  | NZ SACT heamatology disease response | retired | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mds-disease-response  | NZ SACT myelodysplastic syndrome disease response | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mo-disease-response  | NZ SACT medical oncology disease response | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-non-small-lymphocytic-disease-response  | NZ SACT lymphoma (non small lymphocytic) disease response | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-overall-discontinue-reason  | NZ SACT overall discontinue reason | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-patient-factor-discontinue-reason  | NZ SACT patient factor discontinue | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-pr-expression  | NZ SACT PR expression | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-toxicity-discontinue-reason  | NZ systemic anti-cancer therapy toxicity discontinue reason | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side-mandatory  | NZ cancer side mandatory | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side  | NZ cancer side | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-simple-performance-status  | NZ cancer simple performance status | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-cancer-type  | NZ cancer skin cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-extremity-topography  | NZ cancer skin of extremity topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-head-neck-topography  | NZ cancer skin of head and neck topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-melanoma-substream  | NZ cancer skin and melanoma substream | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-topography  | NZ cancer skin topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-trunk-topography  | NZ cancer skin of trunk topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-abdomen-pelvis-topography  | NZ cancer soft tissue abdomen and pelvis topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-cancer-type  | NZ cancer soft tissue and bone cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-substream  | NZ cancer soft tissue and bone substream | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-extremity-topography  | NZ cancer soft tissue extremity topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-head-neck-topography  | NZ cancer soft tissue head and neck topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-skin-topography  | NZ cancer soft tissue skin topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-thoracic-topography  | NZ cancer soft tissue thoracic topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-non-ajcc-staging-system  | NZ cancer solid tumour non-AJCC staging system | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-sact-cancer-type  | NZ cancer solid tumour SACT cancer type | retired | 2024-08 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-staging-system  | NZ cancer solid tumour staging system | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-substream  | NZ cancer solid tumour substream | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category-excision-biopsy  | NZ cancer specimen category biopsy or excision | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category  | NZ cancer specimen category | active | 2024-09 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-colorectal-screening-colonoscopy-type  | NZ cancer colorectal screening colonoscopy specimen type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-dimension-type  | NZ cancer specimen dimension type | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-polyp-profile  | NZ cancer polyp profile type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-stage-classification  | NZ cancer stage classification | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-intent  | NZ surgical intent | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-proximal-distal  | NZ cancer surgical margin qualifier proximal or distal | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-type  | NZ cancer surgical margin type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-t-nk-cell-lymphoma-cancer-type  | NZ cancer T/NK cell lymphoma cancer type | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-failure-reason  | NZ cancer test failure reason | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-inconclusive-reason  | NZ cancer test inconclusive reason | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thoracic-cancer-type  | NZ cancer thoracic cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-lung-lobe-topography  | NZ cancer thorax lung lobe topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-soft-tissue-topography  | NZ cancer thorax soft tissue topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-thymus-topography  | NZ cancer thorax thymus topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-topography  | NZ cancer thorax topography | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thryoid-topography  | NZ cancer thryoid topography | retired | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thyroid-topography  | NZ cancer thyroid topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-b-lymphoma-stage  | NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stage | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-clinical-stage-group  | NZ AJCC breast clinical stage group | retired | 2024-08 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-cm  | NZ AJCC breast clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-ct  | NZ AJCC breast clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pathological-stage-group  | NZ AJCC breast pathological stage group | retired | 2024-08 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pn  | NZ AJCC breast pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pt  | NZ AJCC breast pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-stage-group  | NZ AJCC breast stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-clinical-stage-group  | NZ AJCC clinical stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-cm  | NZ AJCC clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-gen-corpus-uteri-leiomyosarcoma-stage-group  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-cm  | NZ AJCC female genital cervix uteri clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-ct  | NZ AJCC female genital cervix uteri clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pm  | NZ AJCC female genital cervix uteri pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pt  | NZ AJCC female genital cervix uteri pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-stage-group  | NZ AJCC female genital cervix uteri stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-cn  | NZ AJCC female genital corpus uteri adenosarcoma clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-pt  | NZ AJCC female genital corpus uteri adenosarcoma pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-cn  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-ct  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-pt  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-stage-group  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-cm  | NZ AJCC female genital corpus uteri clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-cn  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-ct  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-pt  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pm  | NZ AJCC female genital corpus uteri pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pn  | NZ AJCC female genital corpus uteri pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pt  | NZ AJCC female genital corpus uteri pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-stage-group  | NZ AJCC female genital corpus uteri stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ct  | NZ AJCC female genital clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-pm  | NZ AJCC female genital gestational trophoblastic disease pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-stage-group  | NZ AJCC female genital gestational trophoblastic disease stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-cm  | NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-pt  | NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-pm  | NZ AJCC female genital pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-cn  | NZ AJCC female genital vagina clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pm  | NZ AJCC female genital vagina pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pn  | NZ AJCC female genital vagina pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pt  | NZ AJCC female genital vagina pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-stage-group  | NZ AJCC female genital vagina stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-ct  | NZ AJCC female genital vulva clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pm  | NZ AJCC female genital vulva pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pn  | NZ AJCC female genital vulva pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pt  | NZ AJCC female genital vulva pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-clinical-stage-group  | NZ AJCC gastrointestinal clinical stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-cn  | NZ AJCC gastrointestinal clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cm  | NZ AJCC gastrointestinal colon and rectum clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cn  | NZ AJCC gastrointestinal colon and rectum clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-ct  | NZ AJCC gastrointestinal colon and rectum clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-pn  | NZ AJCC gastrointestinal colon and rectum pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-stage-group  | NZ AJCC gastrointestinal colon and rectum stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-pn  | NZ AJCC gastrointestinal pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-yp-stage-group  | NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cm  | NZ AJCC gastrointestinal stromal tumour clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cn  | NZ AJCC gastrointestinal stromal tumour clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-ct  | NZ AJCC gastrointestinal stromal tumour clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-other-stage-group  | NZ AJCC gastrointestinal stromal tumour small intestine and oesophageal and colon and rectum and mesenteric and peritoneal stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-pm  | NZ AJCC gastrointestinal stromal tumour pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-pn  | NZ AJCC gastrointestinal stromal tumour pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-cll-or-sll-stage-group  | NZ AJCC haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-cn  | NZ AJCC haematology clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-hl-or-nhl-stage-group  | NZ AJCC haematology Hodgkin or non-Hodgkin lymphoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-cm  | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-cn  | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-ct  | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pm  | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pn  | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pt  | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-cm  | NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-ct  | NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-pm  | NZ AJCC haematology cutaneous B cell or T cell non Mycosis fungoides and non-sezary syndrome lymphoma pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-paed-hl-stage-group  | NZ AJCC haematology pediatric Hodgkin lymphoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-pn  | NZ AJCC haematology pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-pt  | NZ AJCC haematology pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-cm  | NZ AJCC neuroendocrine gastrointestinal colon and rectum clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-pt  | NZ AJCC neuroendocrine gastrointestinal colon and rectum pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-stage-group  | NZ AJCC neuroendocrine gastrointestinal colon and rectum stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-ct  | NZ AJCC neuroendocrine gastrointestinal clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-pm  | NZ AJCC neuroendocrine gastrointestinal pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-pn  | NZ AJCC neuroendocrine gastrointestinal pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-stage-group  | NZ AJCC neuroendocrine gastrointestinal stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pathological-stage-group  | NZ AJCC pathological stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pm  | NZ AJCC pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pt  | NZ AJCC pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-rcn  | NZ AJCC recurrence or retreatment clinical N category (rcN) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-rpn  | NZ AJCC recurrence or retreatment pathological N category (rpN) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-stage-classification  | NZ TNM stage classification | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-stage-clinical-classification  | NZ clinical TNM stage classification | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-suffix  | NZ TNM suffix | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-cn  | NZ AJCC thoracic clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-ct  | NZ AJCC thoracic clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-cm  | NZ AJCC thoracic lung clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-cn  | NZ AJCC thoracic lung clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-stage-group  | NZ AJCC thoracic lung stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-cn  | NZ AJCC thoracic malignant pleural mesothelioma clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pm  | NZ AJCC thoracic malignant pleural mesothelioma pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pn  | NZ AJCC thoracic malignant pleural mesothelioma pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pt  | NZ AJCC thoracic malignant pleural mesothelioma pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-stage-group  | NZ AJCC thoracic malignant pleural mesothelioma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pn  | NZ AJCC thoracic pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-stage-group  | NZ AJCC thoracic stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-cm  | NZ AJCC thoracic thymus clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-cn  | NZ AJCC thoracic thymus clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-ct  | NZ AJCC thoracic thymus clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-pt  | NZ AJCC thoracic thymus pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-stage-group  | NZ AJCC thoracic thymus stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-ypn  | NZ AJCC post therapy (neoadjuvant) pathological N category (ypN) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-clinical-stage-group  | NZ AJCC (8th edition) breast clinical stage group | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-cn  | NZ AJCC (8th edition) breast clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-ct  | NZ AJCC (8th edition) breast clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-pn  | NZ AJCC (8th edition) breast pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-pt  | NZ AJCC (8th edition) breast pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-gen-ovary-fallopian-peritoneal-stage-group  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-cm  | NZ AJCC (8th edition) female genital cervix uteri clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-pt  | NZ AJCC (8th edition) female genital cervix uteri pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-stage-group  | NZ AJCC (8th edition) female genital cervix uteri stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cn  | NZ AJCC (8th edition) female genital clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-ct  | NZ AJCC (8th edition) female genital corpus uteri adenosarcoma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-pt  | NZ AJCC (8th edition) female genital corpus uteri adenosarcoma pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-ct  | NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-stage-group  | NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-cn  | NZ AJCC (8th edition) female genital corpus uteri clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-cn  | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-ct  | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-pt  | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-pn  | NZ AJCC (8th edition) female genital corpus uteri pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-pt  | NZ AJCC (8th edition) female genital corpus uteri pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-stage-group  | NZ AJCC (8th edition) female genital corpus uteri stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ct  | NZ AJCC (8th edition) female genital clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-gestational-pm  | NZ AJCC (8th edition) female genital gestational trophoblastic disease pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-gestational-stage-group  | NZ AJCC (8th edition) female genital gestational trophoblastic disease stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-cm  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-ct  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pm  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pn  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-pm  | NZ AJCC (8th edition) female genital pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-pt  | NZ AJCC (8th edition) female genital pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-stage-group  | NZ AJCC (8th edition) female genital stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-pm  | NZ AJCC (8th edition) female genital vagina pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-pt  | NZ AJCC (8th edition) female genital vagina pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-stage-group  | NZ AJCC (8th edition) female genital vagina stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-cm  | NZ AJCC (8th edition) female genital vulva clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-cn  | NZ AJCC (8th edition) female genital vulva clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pm  | NZ AJCC (8th edition) female genital vulva pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pn  | NZ AJCC (8th edition) female genital vulva pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pt  | NZ AJCC (8th edition) female genital vulva pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-stage-group  | NZ AJCC (8th edition) female genital vulva stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-clinical-stage-group  | NZ AJCC (8th edition) gastrointestinal clinical stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-cn  | NZ AJCC (8th edition) gastrointestinal colon and rectum clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-ct  | NZ AJCC (8th edition) gastrointestinal colon and rectum clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pm  | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pn  | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pt  | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-stage-group  | NZ AJCC (8th edition) gastrointestinal colon and rectum stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pathological-stage-group  | NZ AJCC (8th edition) gastrointestinal pathological stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pn  | NZ AJCC (8th edition) gastrointestinal pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pt  | NZ AJCC (8th edition) gastrointestinal pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-yp-stage-group  | NZ AJCC (8th edition) gastrointestinal pathological post therapy (neoadjuvant) stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-cn  | NZ AJCC (8th edition) gastrointestinal stromal tumour clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-ct  | NZ AJCC (8th edition) gastrointestinal stromal tumour clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pm  | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pn  | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pt  | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-cm  | NZ AJCC (8th edition) haematology clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-cn  | NZ AJCC (8th edition) haematology clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-ct  | NZ AJCC (8th edition) haematology clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-hl-or-nhl-stage-group  | NZ AJCC (8th edition) haematology Hodgkin or non Hodgkin lymphoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-cm  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-cn  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-ct  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pm  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pn  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pt  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-cm  | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-ct  | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pm  | NZ AJCC (8th edition) haematology cutaneous B cell or T cell non mycosis fungoides and non sezary syndrome lymphoma pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pt  | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-paed-hl-stage-group  | NZ AJCC (8th edition) haematology pediatric Hodgkin lymphoma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-pcm-stage-group  | NZ AJCC (8th edition) haematology plasma cell myeloma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-pn  | NZ AJCC (8th edition) haematology pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-stage-group  | NZ AJCC (8th edition) haematology stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-cn  | NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cm  | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cn  | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pm  | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pt  | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pm  | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pn  | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pt  | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-stage-group  | NZ AJCC (8th edition) neuroendocrine gastrointestinal stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-cm  | NZ AJCC (8th edition) thoracic clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-ct  | NZ AJCC (8th edition) thoracic lung clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-pn  | NZ AJCC (8th edition) thoracic lung pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-pt  | NZ AJCC (8th edition) thoracic lung pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-stage-group  | NZ AJCC (8th edition) thoracic lung stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-cn  | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-ct  | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-pm  | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-stage-group  | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pn  | NZ AJCC (8th edition) thoracic pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pt  | NZ AJCC (8th edition) thoracic pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-cm  | NZ AJCC (8th edition) thoracic thymus clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-cn  | NZ AJCC (8th edition) thoracic thymus clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-pm  | NZ AJCC (8th edition) thoracic thymus pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-stage-group  | NZ AJCC (8th edition) thoracic thymus stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-cm  | NZ AJCC (9th edition) female genital cervix uteri clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-cn  | NZ AJCC (9th edition) female genital cervix uteri clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-ct  | NZ AJCC (9th edition) female genital cervix uteri clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-pt  | NZ AJCC (9th edition) female genital cervix uteri pathological T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-stage-group  | NZ AJCC (9th edition) female genital cervix uteri stage group | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cm  | NZ AJCC (9th edition) female genital clinical M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cn  | NZ AJCC (9th edition) female genital clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-ct  | NZ AJCC (9th edition) female genital clinical T category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-pm  | NZ AJCC (9th edition) female genital pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-pn  | NZ AJCC (9th edition) female genital pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-cn  | NZ AJCC (9th edition) female genital vulva clinical N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-pm  | NZ AJCC (9th edition) female genital vulva pathological M category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-pn  | NZ AJCC (9th edition) female genital vulva pathological N category | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-treatment-intent  | NZ cancer treatment intent | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tumour-focality  | NZ cancer tumour focality | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tumour-origin  | NZ cancer tumour origin | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-unknown-site-topography  | NZ cancer unknown site topography | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-upper-gastro-cancer-type  | NZ cancer upper gastrointestinal cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-kidney-topography  | NZ cancer urinary and male genital kidney topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-prostate-topography  | NZ cancer urinary and male genital prostate topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-renal-pelvis-ureter-topography  | NZ cancer urinary and male genital renal pelvis and ureter topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testicular-adnexa-topography  | NZ cancer urinary and male genital testicular adnexa topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testicular-topography  | NZ cancer urinary and male genital testicular topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testis-topography  | NZ cancer urinary and male genital testis topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-urinary-bladder-topography  | NZ cancer urinary and male genital urinary bladder topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-system-cancer-type  | NZ cancer urinary system cancer type | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-topography  | NZ cancer urinary system topography | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-aggressive-nh-bcell-lymphoma-histology  | NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma histology | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-anus-primary-histology  | NZ WHO anus primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-appendix-site-histology  | NZ WHO appendix site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bladder-primary-histology  | NZ WHO urinary bladder primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bone-haematolymphoid-histology  | NZ WHO bone haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bone-histology  | NZ WHO bone histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-brain-primary-histology  | NZ WHO brain primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-brain-site-histology  | NZ WHO brain site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-haematolymphoid-histology  | NZ WHO breast haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-in-situ-carcinoma-histology  | NZ WHO breast ductal carcinoma in situ histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-invasive-carcinoma-histology  | NZ WHO breast invasive carcinoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-invasive-histology  | NZ WHO breast invasive histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-nipple-histology  | NZ WHO breast tumour of nipple histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-primary-histology  | NZ WHO breast primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-uncertain-borderline-histology  | NZ WHO breast uncertain and borderline histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-cranial-paraspinal-nerve-histology  | NZ WHO central nervous system cranial and paraspinal nerve histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-grade  | NZ WHO central nervous system tumour grade reference set | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-haematolymphoid-histology  | NZ WHO central nervous system haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-melanocytic-histology  | NZ WHO central nervous system melanocytic histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-meningioma-histology  | NZ WHO central nervous system meningioma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-pineal-histology  | NZ WHO central nervous system pineal histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-sellar-region-histology  | NZ WHO central nervous system sellar region histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-colorectal-primary-histology  | NZ WHO colorectal primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-colorectal-site-histology  | NZ WHO colorectal site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-conjunctiva-primary-histology  | NZ WHO conjunctiva primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-differentiation-excl-undifferentiated-grade  | NZ WHO malignant differentiation excluding undifferentiated grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-differentiation-grade  | NZ WHO malignant differentiation grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-appendix-histology  | NZ WHO digestive system appendix histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-colon-rectum-histology  | NZ WHO digestive system colon and rectum histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-malignant-histology  | NZ WHO digestive system malignant tumour histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-mesenchymal-histology  | NZ WHO digestive system mesenchymal histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-oesophagus-histology  | NZ WHO digestive system oesophagus histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-uncertain-histology  | NZ WHO digestive system uncertain behaviour tumour histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-histology  | NZ WHO endocrine and neuroendocrine adrenal gland histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-primary-histology  | NZ WHO endocrine and neuroendocrine adrenal cortex primary histology | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-site-histology  | NZ WHO endocrine and neuroendocrine adrenal cortex site histology | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-medulla-primary-histology  | NZ WHO endocrine and neuroendocrine adrenal medulla primary histology | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-primary-histology  | NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-site-histology  | NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-germ-cell-histology  | NZ WHO endocrine and neuroendocrine germ cell histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-malignant-histology  | NZ WHO endocrine and neuroendocrine malignant histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-paraganglioma-primary-histology  | NZ WHO endocrine and neuroendocrine paraganglioma primary histology | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-parathyroid-primary-histology  | NZ WHO endocrine and neuroendocrine parathyroid gland primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-parathyroid-site-histology  | NZ WHO endocrine and neuroendocrine parathyroid gland site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-pituitary-histology  | NZ WHO endocrine and neuroendocrine pituitary gland histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-primary-pituitary-histology  | NZ WHO endocrine and neuroendocrine pituitary gland primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-primary-pituitary-net-histology  | NZ WHO pituitary neuroendocrine tumour primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-thyroid-histology  | NZ WHO endocrine and neuroendocrine thyroid gland histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-thyroid-primary-histology  | NZ WHO endocrine and neuroendocrine thyroid gland primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-uncertain-histology  | NZ WHO endocrine and neuroendocrine uncertain behaviour histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-primary-histology  | NZ WHO endocrine primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-behaviour-free-histology  | NZ WHO eye and orbit behaviour free histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-eyelid-histology  | NZ WHO eye and orbit eyelid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-haematolymphoid-histology  | NZ WHO eye and orbit haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-in-situ-histology  | NZ WHO eye and orbit in situ histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-lacrimal-gland-histology  | NZ WHO eye and orbit lacrimal gland histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-optic-disc-nerve-histology  | NZ WHO eye and orbit optic disc and optic nerve histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-uveal-tract-histology  | NZ WHO eye and orbit uveal tract histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eyelid-site-histology  | NZ WHO eyelid site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-fallopian-tube-primary-histology  | NZ WHO fallopian tube primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-breast-primary-minus-nipple-histology  | NZ WHO female breast primary (no nipple) histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-gestational-trophoblastic-histology  | NZ WHO female genital gestational trophoblastic disease histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-haematolymphoid-histology  | NZ WHO female genital haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-histology  | NZ WHO female genital histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-melanocytic-histology  | NZ WHO female genital melanocytic lesion histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-mesenchymal-histology  | NZ WHO female genital mesenchymal tumour of lower genital tract histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-neuroendocrine-histology  | NZ WHO female genital neuroendocrine histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-ovary-histology  | NZ WHO female genital ovary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-peritoneum-histology  | NZ WHO female genital peritoneum histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-uterine-ligament-histology  | NZ WHO female genital uterine ligament histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-vagina-histology  | NZ WHO female genital vagina histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-vulva-histology  | NZ WHO female genital vulva histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-gep-net-primary-histology  | NZ WHO neuroendocrine tumour gastroenteropancreatic (GEP-NET) primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-gestational-trophoblastic-site-histology  | NZ WHO gestational trophoblastic site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-bcell-histology  | NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-histology  | NZ WHO haematolymphoid acute lymphoblastic leukaemia histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-tcell-histology  | NZ WHO haematolymphoid T lymphoblastic leukemia histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-histology  | NZ WHO hematolymphoid B cell lymphoid proliferation or lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-lymphoid-histology  | NZ WHO haematolymphoid B cell lymphoid neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-lymphoma-histology  | NZ WHO haematolymphoid B cell lymphoma histology | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-bl-histology  | NZ WHO haematolymphoid Burkitt lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-castleman-disorder-histology  | NZ WHO haematolymphoid Castleman disease histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-chronic-leukaemia-histology  | NZ WHO haematolymphoid chronic leukaemia histology | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cmml-histology  | NZ WHO haematolymphoid chronic myelomonocytic leukaemia histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cnl-histology  | NZ WHO haematolymphoid chronic neutrophilic leukaemia histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cutaneous-t-cell-lymphoma-histology  | NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-et-histology  | NZ WHO haematolymphoid essential thrombocythaemia histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoid-histology  | NZ WHO haematolymphoid extranodal NK/T cell lymphoid proliferation histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoma-histology  | NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology | retired | 2024-07 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-hcl-histology  | NZ WHO haematolymphoid hairy cell leukaemia histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-histiocytic-histology  | NZ WHO hematolymphoid histiocytic dendritic cell neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-histiocytic-other-histology  | NZ WHO haematolymphoid histiocytic dendritic cell neoplasm other histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-intestinal-nk-t-cell-lymphoid-histology  | NZ WHO classification of tumours haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-leukaemia-histology  | NZ WHO haematolymphoid leukaemia histology | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-lymphoma-not-sll-histology  | NZ WHO haematolymphoid lymphoma excluding small lymphocytic disease histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-lymphoplasmacytic-lymphoma-histology  | NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mast-cell-sarcoma-histology  | NZ WHO haematolymphoid mast cell sarcoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mastocytosis-other-histology  | NZ WHO haematolymphoid mastocytosis other histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mc-lymphoma-histology  | NZ WHO haematolymphoid mantle cell lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-histology  | NZ WHO haematolymphoid myelodysplastic syndrome histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-myeloproliferative-histology  | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-myeloproliferative-other-histology  | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm other histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mpn-other-histology  | NZ WHO haematolymphoid myeloproliferative neoplasm other leukaemia histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-histology  | NZ WHO hematolymphoid myeloid proliferation or neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-other-histology  | NZ WHO haematolymphoid myeloid proliferation or neoplasm other histology | retired | 2024-09 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-secondary-histology  | NZ WHO classification of tumours haematolymphoid secondary myeloid neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloma-histology  | NZ WHO haematolymphoid myeloma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloproliferative-neoplasm-histology  | NZ WHO haematology chronic myeloproliferative neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mzl-histology  | NZ WHO haematolymphoid marginal zone lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-plasma-cell-other-histology  | NZ WHO haematolymphoid plasma cell neoplasm and other diseases with paraproteins other histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-primary-cns-lymphoma-histology  | NZ WHO haematolymphoid primary CNS lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-sll-histology  | NZ WHO haematolymphoid small lymphocytic lymphoma histology | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-stroma-histology  | NZ WHO hematolymphoid stroma derived neoplasm of lymphoid tissue histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-sys-mastocytosis-histology  | NZ WHO haematolymphoid systemic mastocytosis histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-t-nk-cell-histology  | NZ WHO hematolymphoid T cell and NK cell lymphoid proliferation or lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-t-nk-cell-other-histology  | NZ WHO haematolymphoid T-cell and natural killer cell neoplasm other histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-benign-histology  | NZ WHO classification of tumours head and neck benign histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-ear-histology  | NZ WHO classification of tumours head and neck ear histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-germ-cell-histology  | NZ WHO classification of tumours head and neck germ cell tumour histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-haematolymphoid-histology  | NZ WHO classification of tumours head and neck haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-histology  | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-primary-histology  | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-site-histology  | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-malignant-histology  | NZ WHO classification of tumours head and neck malignant histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-melanocytic-histology  | NZ WHO classification of tumours head and neck melanocytic histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-primary-histology  | NZ WHO classification of tumours head and neck nasal primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-site-histology  | NZ WHO classification of tumours head and neck nasal site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-histology  | NZ WHO classification of tumours head and neck nasal and paranasal and skull base histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-primary-histology  | NZ WHO classification of tumours head and neck nasal and paranasal and skull base primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-site-histology  | NZ WHO classification of tumours head and neck nasal and paranasal and skull base site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasopharynx-histology  | NZ WHO classification of tumours head and neck nasopharynx histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasopharynx-site-histology  | NZ WHO classification of tumours head and neck nasopharynx site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-neuro-paragang-histology  | NZ WHO classification of tumours head and neck neuroendocrine neoplasm and paraganglioma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-odontogenic-maxfac-histology  | NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-odontogenic-maxfac-primary-histology  | NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oral-cavity-histology  | NZ WHO classification of tumours head and neck oral cavity and mobile tongue histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oral-cavity-primary-histology  | NZ WHO classification of tumours head and neck oral cavity and mobile tongue primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oropharynx-histology  | NZ WHO classification of tumours head and neck oropharynx histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oropharynx-primary-histology  | NZ WHO classification of tumours head and neck oropharynx primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-pharynx-larynx-trachea-primary-histology  | NZ WHO classification of tumours head and neck pharynx and larynx and trachea primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-pharynx-larynx-trachea-site-histology  | NZ WHO classification of tumours head and neck pharynx and larynx and trachea site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-histology  | NZ WHO classification of tumours head and neck salivary gland histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-primary-histology  | NZ WHO classification of tumours head and neck salivary gland primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-site-histology  | NZ WHO classification of tumours head and neck salivary gland site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-soft-tissue-histology  | NZ WHO classification of tumours head and neck soft tissue histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-uncertain-histology  | NZ WHO classification of tumours head and neck uncertain behaviour histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-heart-primary-histology  | NZ WHO heart primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology-cll-histology  | NZ WHO haematolymphoid chronic lymphocytic leukaemia histology | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology-plasmacytoid-dendritic-histology  | NZ WHO haematolymphoid plasmacytoid dendritic cell neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology  | NZ WHO histology | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-b-cell-lymphoma-other-histology  | NZ WHO haematolymphoid indolent B cell lymphoma other histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-bcell-lymphoma-histology  | NZ WHO haematolymphoid indolent B cell lymphoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-nh-b-cell-lymphoma-other-histology  | NZ WHO haematolymphoid indolent non-hodgkin B cell lymphoma other histology | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-kidney-primary-histology  | NZ WHO kidney primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-drainage-system-primary-histology  | NZ WHO lacrimal drainage system primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-gland-primary-histology  | NZ WHO lacrimal gland primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-gland-site-histology  | NZ WHO lacrimal gland site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-liver-site-histology  | NZ WHO liver site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-low-high-diff-grade  | NZ WHO malignant low high (differentiation) grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lower-gastro-primary-histology  | NZ WHO lower gastrointestinal primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lower-gastro-site-histology  | NZ WHO lower gastrointestinal site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-male-breast-primary-histology  | NZ WHO male breast primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mature-tnk-cell-other-histology  | NZ WHO haematolymphoid mature T-cell and natural killer cell neoplasm other histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mature-tnk-leukaemia-histology  | NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-melanoma-cns-primary-histology  | NZ WHO classification of CNS melanoma primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-melanoma-primary-histology  | NZ WHO classification of melanoma primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-meninges-primary-histology  | NZ WHO meninges primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mo-histology  | NZ WHO medical oncology histology | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-net-non-endo-organ-primary-histology  | NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-non-endo-organ-histology  | NZ WHO neuroendocrine neoplasm non neuroendocrine organ histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-pancreas-histology  | NZ WHO neuroendocrine pancreas histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-pancreas-primary-histology  | NZ WHO neuroendocrine pancreas primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendocrine-grade  | NZ WHO neuroendocrine tumour grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-oesophagus-primary-histology  | NZ WHO oesophagus primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-orbit-histology  | NZ WHO orbit histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-orbit-primary-histology  | NZ WHO orbit primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-ovary-primary-histology  | NZ WHO ovary primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-ovary-site-histology  | NZ WHO ovary site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pancreas-primary-histology  | NZ WHO pancreas primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pancreas-site-histology  | NZ WHO pancreas site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-penis-primary-histology  | NZ WHO penis primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-penis-site-histology  | NZ WHO penis site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pericardium-primary-histology  | NZ WHO pericardium primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pericardium-site-histology  | NZ WHO pericardium site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-peritoneum-site-histology  | NZ WHO peritoneum site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pleura-site-histology  | NZ WHO pleural site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-prostate-primary-histology  | NZ WHO prostate primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-prostate-site-histology  | NZ WHO prostate site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-sclera-primary-histology  | NZ WHO sclera primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-heamatolymphoid-histology  | NZ WHO classification of tumours skin haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-keratinocytic-epidermal-histology  | NZ WHO classification of tumours skin keratinocytic and epidermal histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-malignant-histology  | NZ WHO classification of tumours skin malignant histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-melanocytic-histology  | NZ WHO classification of tumours skin melanocytic neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-merkel-primary-histology  | NZ WHO classification of Merkel cell carcinoma primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-precursor-histology  | NZ WHO classification of tumours skin precursor histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-squamous-primary-histology  | NZ WHO classification of squamous cell carcinoma primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-small-intestine-primary-histology  | NZ WHO small intestine primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-small-intestine-site-histology  | NZ WHO small intestine site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-bone-undiff-sarcoma-histology  | NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-histology  | NZ WHO soft tissue histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-primary-histology  | NZ WHO soft tissue primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-site-histology  | NZ WHO soft tissue site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-spinal-cord-site-histology  | NZ WHO spinal cord site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-stomach-primary-histology  | NZ WHO stomach primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testicular-adnexa-primary-histology  | NZ WHO testicular adnexa primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testicular-adnexa-site-histology  | NZ WHO testicular adnexa site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testis-primary-histology  | NZ WHO testis primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testis-site-histology  | NZ WHO testis site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-benign-histology  | NZ WHO thoracic benign histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-ectopic-thyroid-parathyroid-histology  | NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-haematolymphoid-histology  | NZ WHO thoracic haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-malignant-histology  | NZ WHO thoracic malignant histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-mesenchymal-histology  | NZ WHO thoracic mesenchymal thorax histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-neuroendocrine-grade  | NZ WHO thoracic neuroendocrine tumour grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-non-small-cell-lung-histology  | NZ WHO thoracic non small cell lung histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-pleura-pericardium-histology  | NZ WHO thoracic pleura and pericardium histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-precursor-histology  | NZ WHO thoracic precursor histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-primary-histology  | NZ WHO thoracic primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-small-cell-lung-histology  | NZ WHO thoracic small cell lung histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-upper-gastro-primary-histology  | NZ WHO upper gastrointestinal primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-upper-gastro-site-histology  | NZ WHO upper gastrointestinal site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-primary-histology  | NZ WHO urethra primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-site-histology  | NZ WHO urethra site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-histology  | NZ WHO urinary and male genital histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-kidney-germ-cell-histology  | NZ WHO urinary and male genital kidney germ cell histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-kidney-histology  | NZ WHO urinary and male genital kidney histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-neuroendocrine-histology  | NZ WHO urinary and male genital neuroendocrine histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-primary-histology  | NZ WHO urinary and male genital primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-prostate-histology  | NZ WHO urinary and male genital prostate histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testicular-adnexa-histology  | NZ WHO urinary and male genital testicular adnexa histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testis-germ-cell-histology  | NZ WHO urinary and male genital testis germ cell histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testis-histology  | NZ WHO urinary and male genital testis histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-system-site-histology  | NZ WHO urinary system site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-corpus-primary-histology  | NZ WHO uterine corpus primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-corpus-site-histology  | NZ WHO uterine corpus site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-ligament-site-histology  | NZ WHO uterine ligament site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-primary-histology  | NZ WHO uterine primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uveal-tract-site-histology  | NZ WHO uveal tract site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vagina-site-histology  | NZ WHO vagina site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vulva-primary-histology  | NZ WHO vulva primary histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vulva-site-histology  | NZ WHO vulva site histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-aggressive-bcell-lymphoma-histology  | NZ WHO haematolymphoid aggressive cell lymphoma histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-aggressive-nh-bcell-lymphoma-histology  | NZ WHO haematolymphoid aggressive non-Hodgkin B cell lymphoma histology (5th edition) | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-bone-histology  | NZ WHO bone histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-behaviour-free-histology  | NZ WHO breast behaviour free histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-benign-histology  | NZ WHO breast benign histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-haematolymphoid-histology  | NZ WHO breast haematolymphoid histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-histology  | NZ WHO breast histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-nipple-histology  | NZ WHO breast tumour of nipple histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-choroid-plexus-histology  | NZ WHO central nervous system choroid plexus histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-cranial-paraspinal-nerve-histology  | NZ WHO central nervous system cranial and paraspinal nerve histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-embryonal-histology  | NZ WHO central nervous system embryonal histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-germ-cell-histology  | NZ WHO central nervous system germ cell histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-glioma-glioneuronal-neuronal-histology  | NZ WHO central nervous system glioma and glioneuronal and neuronal histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-haematolymphoid-histology  | NZ WHO central nervous system haematolymphoid histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-pineal-histology  | NZ WHO central nervous system pineal histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-sellar-region-histology  | NZ WHO central nervous system sellar region histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-differentiation-grade  | NZ WHO (5th edition) malignant differentiation grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-anal-canal-histology  | NZ WHO digestive system anal canal histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-appendix-histology  | NZ WHO digestive system appendix histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-benign-histology  | NZ WHO digestive system benign tumour histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-colon-rectum-hormone-histology  | NZ WHO digestive system colon and rectum hormone producing tumor histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-germ-tumour-histology  | NZ WHO digestive system germ cell tumour histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-haematolymphoid-histology  | NZ WHO digestive system haematolymphoid histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-liver-intrahepatic-bile-duct-histology  | NZ WHO digestive system liver and intrahepatic bile duct histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-mesenchymal-histology  | NZ WHO digestive system mesenchymal histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-precursor-histology  | NZ WHO digestive system precursor tumour histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-uncertain-histology  | NZ WHO digestive system uncertain behaviour tumour histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-adrenal-histology  | NZ WHO endocrine and neuroendocrine adrenal gland histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-benign-histology  | NZ WHO endocrine and neuroendocrine benign histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-malignant-histology  | NZ WHO endocrine and neuroendocrine malignant histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-pituitary-histology  | NZ WHO endocrine and neuroendocrine pituitary gland histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-pituitary-net-histology  | NZ WHO pituitary neuroendocrine tumour primary histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-thyroid-histology  | NZ WHO endocrine and neuroendocrine thyroid gland histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-uncertain-histology  | NZ WHO endocrine and neuroendocrine uncertain behaviour histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-haematolymphoid-histology  | NZ WHO eye and orbit haematolymphoid histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-histology  | NZ WHO eye and orbit histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-lacrimal-gland-histology  | NZ WHO eye and orbit lacrimal gland histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-optic-disc-nerve-histology  | NZ WHO eye and orbit optic disc and optic nerve histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-retina-neuroepithelium-histology  | NZ WHO eye and orbit retina and neuroepithelium histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-soft-tissue-bone-histology  | NZ WHO eye and orbit soft tissue and bone histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-uncertain-borderline-histology  | NZ WHO eye and orbit uncertain and borderline histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-germ-cell-histology  | NZ WHO female genital germ cell histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-haematolymphoid-histology  | NZ WHO female genital haematolymphoid histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-neuroendocrine-histology  | NZ WHO female genital neuroendocrine histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-ovary-histology  | NZ WHO female genital ovary histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-peritoneum-histology  | NZ WHO female genital peritoneum histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-vagina-histology  | NZ WHO female genital vagina histology (5th edition) | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-acute-leukaemia-amb-lineage-histology  | NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-amyloidosis-histology  | NZ WHO haematolymphoid amyloidosis histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-b-cell-lymphoma-histology  | NZ WHO haematolymphoid B cell lymphoma histology (5th edition) | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-b-cell-reactive-lymphoma-histology  | NZ WHO haematolymphoid reactive B-cell rich lymphoid proliferations which mimic lymphoma histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-bl-histology  | NZ WHO haematolymphoid Burkitt lymphoma histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-castleman-disorder-histology  | NZ WHO haematolymphoid Castleman disease histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-cml-histology  | NZ WHO haematolymphoid chronic myeloid leukaemia histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-cutaneous-t-cell-lymphoma-histology  | NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-et-histology  | NZ WHO haematolymphoid essential thrombocythaemia histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-extranod-nk-t-cell-lymphoma-histology  | NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology (5th edition) | retired | 2024-07 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-histiocytic-histology  | NZ WHO haematolymphoid histiocytic dendritic cell neoplasm histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-histology  | NZ WHO haematolymphoid tumour histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-intest-nk-t-cell-lymphoid-histology  | NZ WHO classification of tumours (5th edition) haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-leukaemia-histology  | NZ WHO haematolymphoid leukaemia histology (5th edition) | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-lymphoplasmacytic-lymphoma-histology  | NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mc-lymphoma-histology  | NZ WHO haematolymphoid mantle cell lymphoma histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mds-histology  | NZ WHO haematolymphoid myelodysplastic syndrome histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mds-myeloproliferative-histology  | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloid-lymphoid-gene-histology  | NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloid-secondary-histology  | NZ WHO classification of tumours (5th edition) haematolymphoid secondary myeloid neoplasm histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloproliferative-neoplasm-histology  | NZ WHO haematology chronic myeloproliferative neoplasm histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-nhl-histology  | NZ WHO haematolymphoid non Hodgkin lymphoma histology (5th edition) | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-peripheral-t-cell-lymphoma-histology  | NZ WHO haematolymphoid peripheral T cell lymphoma histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-plasma-cell-histology  | NZ WHO haematolymphoid plasma cell neoplasms and other diseases with paraproteins histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-pv-histology  | NZ WHO haematolymphoid polycythaemia vera histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-benign-histology  | NZ WHO classification of tumours (5th edition) head and neck benign histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-ear-histology  | NZ WHO classification of tumours (5th edition) head and neck ear histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-haematolymphoid-histology  | NZ WHO classification of tumours (5th edition) head and neck haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-histology  | NZ WHO classification of tumours (5th edition) head and neck histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-malignant-histology  | NZ WHO classification of tumours (5th edition) head and neck malignant histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-melanocytic-histology  | NZ WHO classification of tumours (5th edition) head and neck melanocytic histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-nasal-skull-histology  | NZ WHO classification of tumours (5th edition) head and neck nasal and paranasal and skull base histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-nasopharynx-histology  | NZ WHO classification of tumours (5th edition) head and neck nasopharynx histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-neck-lymph-histology  | NZ WHO classification of tumours (5th edition) head and neck tumour and tumour-like lesion of the neck and lymph node histology | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-odontogenic-maxfac-histology  | NZ WHO classification of tumours (5th edition) head and neck odontogenic and maxillofacial bone histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-oral-cavity-histology  | NZ WHO classification of tumours (5th edition) head and neck oral cavity and mobile tongue histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-pharynx-larynx-histology  | NZ WHO classification of tumours (5th edition) head and neck hypopharynx and larynx and trachea and parapharyngeal histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-precursor-histology  | NZ WHO classification of tumours (5th edition) head and neck precursor histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-salivary-histology  | NZ WHO classification of tumours (5th edition) head and neck salivary gland histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-soft-tissue-histology  | NZ WHO classification of tumours (5th edition) head and neck soft tissue histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-histology-cll-histology  | NZ WHO haematolymphoid chronic lymphocytic leukaemia histology (5th edition) | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-indolent-bcell-lymphoma-histology  | NZ WHO haematolymphoid indolent B cell lymphoma histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-indolent-nh-bcell-lymphoma-histology  | NZ WHO haematolymphoid indolent non-Hodgkin B cell lymphoma histology (5th edition) | retired | 2024-05 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-low-high-diff-grade  | NZ WHO (5th edition) malignant low high (differentiation) grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-mature-tnk-cell-histology  | NZ WHO haematolymphoid mature T cell and natural killer cell neoplasm histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-mature-tnk-leukaemia-histology  | NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-cns-histology  | NZ WHO classification of tumours (5th edition) CNS melanoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-histology  | NZ WHO classification of tumours (5th edition) melanoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-mucosal-histology  | NZ WHO classification of tumours (5th edition) mucosal melanoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-monoclonal-b-cell-lymphocytosis-histology  | NZ WHO haematolymphoid monoclonal B cell lymphocytosis histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-net-non-endo-organ-histology  | NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-neuroendo-pancreas-histology  | NZ WHO neuroendocrine pancreas histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-neuroendo-pancreas-net-histology  | NZ WHO neuroendocrine tumour pancreas primary histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-orbit-histology  | NZ WHO orbit histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-heamatolymphoid-histology  | NZ WHO classification of tumours (5th edition) skin haematolymphoid histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-histology  | NZ WHO classification of tumours (5th edition) skin histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-keratinocytic-epidermal-histology  | NZ WHO classification of tumours (5th edition) skin keratinocytic and epidermal histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-merkel-histology  | NZ WHO classification of tumours (5th edition) Merkel cell carcinoma histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-precursor-histology  | NZ WHO classification of tumours (5th edition) skin precursor histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-soft-tissue-histology  | NZ WHO classification of tumours (5th edition) skin soft tissue histology | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-soft-tissue-bone-undiff-sarcoma-histology  | NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-benign-histology  | NZ WHO thoracic benign histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-ectopic-thyroid-parathyroid-histology  | NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-germ-cell-mediastinum-histology  | NZ WHO thoracic mediastinum germ cell histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-haematolymphoid-mediastinum-histology  | NZ WHO thoracic mediastinum haematolymphoid histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-heart-histology  | NZ WHO thoracic heart histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-neuroendocrine-grade  | NZ WHO (5th edition) thoracic neuroendocrine tumour grade | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-non-small-cell-lung-histology  | NZ WHO thoracic non small cell lung histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-pleura-pericardium-histology  | NZ WHO thoracic pleura and pericardium histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-precursor-histology  | NZ WHO thoracic precursor histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-small-cell-lung-histology  | NZ WHO thoracic small cell lung histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-haematolymphoid-histology  | NZ WHO urinary and male genital haematolymphoid histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-histology  | NZ WHO urinary and male genital histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-kidney-histology  | NZ WHO urinary and male genital kidney histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-prostate-histology  | NZ WHO urinary and male genital prostate histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-testis-germ-cell-histology  | NZ WHO urinary and male genital testis germ cell histology (5th edition) | active | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/clinical-code-type-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/uv/ips/ValueSet/condition-severity-uv-ips  | Problem Severity - IPS | active | 2022-11 | | national | loinc |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/condition-severity  | Condition/Diagnosis Severity | draft | 2019-11 | | national | sct |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/condition-ver-status  | | draft | 2024-11 | | national | tho |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/contact-point-purpose-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/currency  | Currency | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-hypercholesterolaemia  | CVDRA Hypercholesterolaemia | draft | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/atc-value-set  | ATC value set | draft | 2024-11 | | national | atc |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/dhb-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/document-mode  | DocumentMode | active | 2019-11 | | national | fhir |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/dod-information-source-code  | Death date Information Source | active | 2023-10 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/domicile-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/dwelling-type  | Dwelling type | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/ethnic-group-level-4-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nz-ethnic-group-code-level-1  | NZ ethnic group code level 1 | active | 2023-06 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-angina  | CVDRA Angina | draft | 2024-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/gender-classification  | Standard classification of gender | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/healthnz-language-value-set  | Health NZ language Value Set | draft | 2024-11 | | national | tho |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/hpi-practitioner-role-status-reason-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/iso-639-2-and-3  | ISO 639 2 and 3 language codes | draft | 2024-11 | | national | tho |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/iso3166-1-2  | | draft | 2024-11 | | national | iso |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/iwi-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/uv/ips/ValueSet/medication-snomed-uv-ips  | Medications - SNOMED CT (IPS) | active | 2022-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nz-datum-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nz-ethnic-group-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nzmt-ctpp  | NZMT - CTPP | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nzmt-mp  | NZMT - MP | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nzmt-mpuu  | NZMT - MPUU | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nzmt-tpp  | NZMT - TPP | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nzmt-type-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nzpocs  | NZPOCS | active | 2024-11 | | national | loinc |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/observation-vitalsignresult  | Vital Signs | active | 2019-11 | | national | loinc |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/oral-enrolment-termination-reason  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-additional-authorisation-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-role-code  | PractitionerRoleCode | active | 2024-10 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-scope-of-practice-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/uv/ips/ValueSet/problems-snomed-uv-ips  | Problems (SNOMED CT) - IPS | active | 2022-11 | | national | sct |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/reason-medication-status-codes  | SNOMED CT Drug Therapy Status codes | draft | 2019-11 | | national | sct |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/uv/ips/ValueSet/result-coded-value-pathology-uv-ips  | Results Coded Values Pathology - IPS | active | 2022-11 | | national | sct |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-coded-values-laboratory-uv-ips  | Results Coded Values Laboratory - IPS | active | 2022-11 | | national | fhir |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-pathology-observations-uv-ips  | Results Pathology Observation - IPS | active | 2022-11 | | national | loinc |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/uv/ips/ValueSet/results-presence-absence-uv-ips  | Results Presence/Absence - IPS | active | 2022-11 | | national | sct |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/skin-to-skin-contact-end-reason-code  | | draft | 2024-11 | | national | |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/ucum-common  | Common UCUM units | draft | 2024-11 | | national | ucum |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/ucum-units  | UCUM Codes | draft | 2019-11 | | national | ucum |
tewhatuora.nzhts | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/ukpul-vs  | UKPUL | draft | 2023-11 | | national | ucum |
tewhatuora.nzhts | R4 | http://hl7.org/fhir/ValueSet/vaccine-code  | | draft | 2024-11 | | national | cvx |
hl7.fhir.uv.crmi | R4 | http://terminology.hl7.org/ValueSet/artifact-resource-types  | Artifact Resource Types | active | 2024-08 | uv | hl7 | fhir |
hl7.fhir.uv.crmi | R4 | crmi-release-experimental-behavior  | CRMI Release Experimental Behavior | active | 2024-08 | uv | hl7 | fhir |
hl7.fhir.uv.crmi | R4 | crmi-release-version-behavior  | CRMI Release Version Behavior | active | 2024-08 | uv | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | AdditionalDocumentation  | CRD Coverage Information Additional Documentation Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | CMSMappableLocationCodes  | CMS Mappable Location Codes | active | 2024-12 | us | hl7 | fhir tho |
hl7.fhir.us.davinci-crd | R4 | DocReason  | CRD Coverage Information Documentation Reason Value Set | active | 2024-12 | us | hl7 | fhir tho |
hl7.fhir.us.davinci-crd | R4 | afterCompletionCode  | CRD After Completion Code Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | cardActions  | CDS Hooks Card Suggestion Action Types Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | cardType  | CRD Card Types Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | cdsHookType  | CDS Hook Types Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | cmslocationcodes  | CMS Location Codes Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | configTypes  | CRD Configuration Code Data Types Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | coverageAssertionReasons  | CRD Coverage Assertion Reasons | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | coverageClass  | CRD Coverage Classes Value Set | active | 2024-12 | us | hl7 | tho |
hl7.fhir.us.davinci-crd | R4 | coverageDetail  | CRD Coverage Detail Codes Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | coverageInfo  | CRD Coverage Information Covered Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | coveragePaDetail  | CRD Coverage Information Prior Authorization Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | deviceRequest  | CRD Device Request Codes Value Set | active | 2024-12 | us | hl7 | cpt cms |
hl7.fhir.us.davinci-crd | R4 | informationNeeded  | CRD Information Needed Value Set | active | 2024-12 | us | hl7 | fhir tho |
hl7.fhir.us.davinci-crd | R4 | locationAddressType  | CRD Location Address Types Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | metricDataSource  | CRD Metric Data Source Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | metricTokenUse  | CRD Metric Token Use | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-crd | R4 | orderDetail  | CRD Order Detail Codes Value Set | active | 2024-12 | us | hl7 | fhir vsac |
hl7.fhir.us.davinci-crd | R4 | serviceRequestCodes  | CRD Service Request Codes Value Set | active | 2024-12 | us | hl7 | sct cpt cms loinc |
hl7.fhir.us.davinci-crd | R4 | taskReason  | CRD Task Reason Codes Value Set | active | 2024-12 | us | hl7 | fhir |
fhir.hrsa.uds-plus | R4 | uds-plus-birthsex-codes  | Uds Plus Birth Sex Codes | active | 2023-08 | us | hl7 | tho |
fhir.hrsa.uds-plus | R4 | uds-plus-gender-identity-codes  | Uds Plus Gender Identity Codes | active | 2023-08 | us | hl7 | vsac tho |
fhir.hrsa.uds-plus | R4 | uds-plus-insurance-codes  | Uds Plus Insurance Codes | active | 2020-09 | us | hl7 | internal |
fhir.hrsa.uds-plus | R4 | uds-plus-service-delivery-codes  | Uds Plus Service Delivery Codes | active | 2023-08 | us | hl7 | internal tho |
fhir.hrsa.uds-plus | R4 | uds-plus-sexual-orientation-codes  | Uds Plus Sexual Orientation Codes | active | 2023-08 | us | hl7 | fhir tho |
fhir.hrsa.uds-plus | R4 | udsplus-agriculture-worker-status  | Uds Plus Agriculture Worker Status Codes | active | 2020-09 | us | hl7 | internal |
fhir.hrsa.uds-plus | R4 | udsplus-housing-status  | Uds Plus Housing Status Codes | active | 2020-09 | us | hl7 | internal |
hl7.fhir.us.pacio-rt | R4 | timepoint-class-vs  | Timepoint Class Value Set | active | 2022-10 | us | hl7 | fhir tho |
hl7.fhir.us.pacio-rt | R4 | timepoint-entity-type-vs  | Timepoint Entity Type Value Set | active | 2022-10 | us | hl7 | fhir |
hl7.fhir.us.pacio-rt | R4 | timepoint-service-type-vs  | Timepoint Service Type Value Set | active | 2022-10 | us | hl7 | fhir |
hl7.fhir.us.pacio-rt | R4 | timepoint-status-vs  | Timepoint Status Value Set | active | 2022-10 | us | hl7 | fhir |
ihe.iti.dsubm | R4 | DSUBmPublishBundleActions  | DSUBm Update to document sharing resources actions ValueSet | active | 2024-10 | uv | ihe | fhir |
ihe.iti.dsubm | R4 | payload-content-value-set  | DSUBm payload admitted Value Set | active | 2024-10 | uv | ihe | ietf |
idmp.who-umc.org.fhir | R5 | atcClassification  | WHO ATC | active | 2024-11 | uv | | atc |
idmp.who-umc.org.fhir | R5 | channelType  | Channel Type Value Set | active | 2024-11 | uv | | tho |
idmp.who-umc.org.fhir | R5 | edqm-AME  | EDQM PDF characteristics: Administration Method | active | 2024-11 | uv | | |
idmp.who-umc.org.fhir | R5 | edqm-BDF  | EDQM PDF characteristics: Basic Dose Form | active | 2024-11 | uv | | |
idmp.who-umc.org.fhir | R5 | edqm-ISI  | EDQM PDF characteristics: Intended Site | active | 2024-11 | uv | | |
idmp.who-umc.org.fhir | R5 | edqm-RCA  | EDQM PDF characteristics: Release Characteristics | active | 2024-11 | uv | | |
idmp.who-umc.org.fhir | R5 | gsid-task-input-type  | GSID request input type value set | active | 2024-11 | uv | | internal |
idmp.who-umc.org.fhir | R5 | gsid-task-output-type  | GSID request output type value set | active | 2024-11 | uv | | internal |
idmp.who-umc.org.fhir | R5 | jurisdiction  | Jurisdiction Value Set | active | 2024-11 | uv | | internal iso |
idmp.who-umc.org.fhir | R5 | mpid-system  | MPID system | active | 2024-11 | uv | | ietf |
idmp.who-umc.org.fhir | R5 | pharmaceuticalForm  | EDQM Pharmaceutical Form | active | 2024-11 | uv | | |
idmp.who-umc.org.fhir | R5 | phpid-task-input-type  | PhPID request input type value set | active | 2024-11 | uv | | internal |
idmp.who-umc.org.fhir | R5 | phpid-task-output-type  | PhPID request output type value set | active | 2024-11 | uv | | internal |
idmp.who-umc.org.fhir | R5 | phpid-type  | Identifier Type Value Set | active | 2024-11 | uv | | internal |
idmp.who-umc.org.fhir | R5 | routeOfAdministration  | Route Of Administration | draft | 2024-11 | uv | | sct |
idmp.who-umc.org.fhir | R5 | strengthUnit  | Strength Unit Value Set | active | 2024-11 | uv | | ucum internal |
idmp.who-umc.org.fhir | R5 | substance  | Substances | active | 2024-11 | uv | | internal |
hl7.fhir.us.dme-orders | R4 | PAOX-Task-Code  | PAO Task Code Value Set | draft | 2023-06 | us | hl7 | fhir |
hl7.fhir.us.dme-orders | R4 | PAOx-Message-Event  | PAO Message Event | draft | 2023-06 | us | hl7 | fhir |
hl7.fhir.dk.hackathon.2022 | R4 | ActivityCodes  | ObservationCodes | draft | 2024-12 | dk | hl7 | sct |
hl7.fhir.dk.hackathon.2022 | R4 | DesireToBeWithOthersCodes  | Lyst til at være sammen med andre | active | 2024-12 | dk | hl7 | internal |
hl7.fhir.dk.hackathon.2022 | R4 | EnergyCodes  | Oplagthed | active | 2024-12 | dk | hl7 | internal |
hl7.fhir.dk.hackathon.2022 | R4 | FriendshipCodes  | Venskaber | active | 2024-12 | dk | hl7 | internal |
hl7.fhir.dk.hackathon.2022 | R4 | LoveCodes  | Kærlighed | active | 2024-12 | dk | hl7 | internal |
hl7.fhir.dk.hackathon.2022 | R4 | MoodCodes  | Humør | active | 2024-12 | dk | hl7 | internal |
hl7.fhir.dk.hackathon.2022 | R4 | ObservationCodesSCT  | ObservationCodesSCT | draft | 2024-12 | dk | hl7 | sct |
hl7.fhir.dk.hackathon.2022 | R4 | PressureCodes  | Pres | active | 2024-12 | dk | hl7 | internal |
hl7.fhir.dk.hackathon.2022 | R4 | WorkSchoolExpectationCodes  | Arbejde/skole forventning | active | 2024-12 | dk | hl7 | internal |
dk.ehmi.terminology | R4 | dk-medcom-message-definition-uri-valueset  | MedCom Message Definition Uri Valueset | active | 2023-09 | dk | | internal |
dk.ehmi.terminology | R4 | ehmi-delivery-status-agent-who-identifier-types-valueset  | EHMI Delivery Status (EDS) AgentWhoIdentifier Types Valueset | active | 2023-09 | dk | | internal dcm |
dk.ehmi.terminology | R4 | ehmi-delivery-status-entity-detail-type-valueset  | EHMI Delivery Status (EDS) Entity Detail Type Valueset | active | 2023-09 | dk | | internal |
dk.ehmi.terminology | R4 | ehmi-delivery-status-entity-message-type-valueset  | EHMI Delivery Status (EDS) Entity MessageType Valueset | active | 2023-09 | dk | | internal |
dk.ehmi.terminology | R4 | ehmi-delivery-status-entity-type-valueset  | EHMI Delivery Status (EDS) Entity Type Valueset | active | 2023-09 | dk | | internal tho |
dk.ehmi.terminology | R4 | ehmi-delivery-status-network-valueset  | EHMI Delivery Status (EDS) Network Valueset | active | 2023-09 | dk | | fhir |
dk.ehmi.terminology | R4 | ehmi-delivery-status-outcome-valueset  | EHMI Delivery Status (EDS) Outcome Valueset | active | 2023-09 | dk | | fhir |
dk.ehmi.terminology | R4 | ehmi-delivery-status-participationroletype-valueset  | EHMI Delivery Status (EDS) ParticipationRoleType Valueset | active | 2023-09 | dk | | internal dcm |
dk.ehmi.terminology | R4 | ehmi-delivery-status-rest-all-read-valueset  | all Reads | draft | 2024-12 | dk | | fhir |
dk.ehmi.terminology | R4 | ehmi-delivery-status-rest-object-roles-valueset  | RESTful objects role in the event | draft | 2024-12 | dk | | tho |
dk.ehmi.terminology | R4 | ehmi-delivery-status-source-type-valueset  | EHMI Delivery Status (EDS) Source Type Valueset | active | 2023-09 | dk | | internal |
dk.ehmi.terminology | R4 | ehmi-delivery-status-sub-types-valueset  | EHMI Delivery Status (EDS) SubTypes Valueset | active | 2023-09 | dk | | internal |
dk.ehmi.terminology | R4 | ehmi-delivery-status-sub-types-valueset2  | EHMI Delivery Status (EDS) SubTypes Valueset | active | 2023-09 | dk | | internal fhir |
dk.ehmi.terminology | R4 | ehmi-delivery-status-types-valueset  | EHMI Delivery Status (EDS) Types Valueset | active | 2023-09 | dk | | internal fhir tho |
hl7.fhir.us.davinci-dtr | R4 | MetricsinformationOrigins  | Information Human Origins Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-dtr | R4 | informationOrigins  | Information Origins Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-dtr | R4 | metric-Action  | Metric Action | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-dtr | R4 | metric-Source  | Metric Source | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-dtr | R4 | metric-launchmode  | Metric Launch Mode | active | 2024-12 | us | hl7 | fhir |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownAllergy  | Absent or Unknown Allergies | active | 2024-12 | eu | hl7 | fhir |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownDevice  | Absent or Unknown Device | active | 2024-12 | eu | hl7 | fhir |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownMedication  | Absent or Unknown Medication | active | 2024-12 | eu | hl7 | fhir |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownProblem  | Absent or Unknown Problem | active | 2024-12 | eu | hl7 | fhir |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownProcedure  | Absent or Unknown Procedure | active | 2024-12 | eu | hl7 | fhir |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIActiveIngredient  | Active Ingredient (PARTIAL) | active | 2024-12 | eu | hl7 | atc |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType  | Adverse Event Type | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug  | Allergen No Drug | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | eHDSIAllergens  | Allergens | draft | 2024-12 | eu | hl7 | |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAllergyCertainty  | Allergy Certainty | active | 2024-12 | eu | hl7 | tho |
hl7.eu.fhir.xpandh.ps | R4 | eHDSIAllergyCode  | Allergens or no known or unknown conditions | draft | 2024-12 | eu | hl7 | |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIAllergyStatus  | Allergy Status | active | 2024-12 | eu | hl7 | tho |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup  | Blood Group | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIBloodPressure  | Blood Pressure | active | 2024-12 | eu | hl7 | loinc |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite  | Body Site | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSICertainty  | Certainty | active | 2024-12 | eu | hl7 | tho |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb  | Problems | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | eHDSICondition  | Conditions | draft | 2024-12 | eu | hl7 | |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIConfidentiality  | Confidentiality | active | 2024-12 | eu | hl7 | tho |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSICountry  | Country | active | 2024-12 | eu | hl7 | iso |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSICriticality  | Criticality | active | 2024-12 | eu | hl7 | fhir |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus  | Current Pregnancy Status | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIDocumentCode  | Document Code | active | 2024-12 | eu | hl7 | loinc |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIDoseForm  | Dose Form | active | 2024-12 | eu | hl7 | |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIHealthcareProfessionalRole  | Healthcare Professional Role | active | 2024-12 | eu | hl7 | oid |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIHospitalDischargeReportType  | Hospital Discharge Report Type | active | 2024-12 | eu | hl7 | loinc |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIIllnessandDisorder  | Illness and Disorder (PARTIAL) | active | 2024-12 | eu | hl7 | icd |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice  | Medical Device (PARTIAL) | active | 2024-12 | eu | hl7 | example |
hl7.eu.fhir.xpandh.ps | R4 | eHDSIProblemCode  | Problems (including unknown conditions) | draft | 2024-12 | eu | hl7 | |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure  | Procedure | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIRareDisease  | Rare Disease (PARTIAL) | active | 2024-12 | eu | hl7 | |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy  | Reaction Allergy | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIRouteofAdministration  | Route of Administration | active | 2024-12 | eu | hl7 | |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSISeverity  | Severity | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory  | eHDSI Social History | active | 2024-12 | eu | hl7 | sct |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSISubstance  | Substance (PARTIAL) | active | 2024-12 | eu | hl7 | |
hl7.eu.fhir.xpandh.ps | R4 | http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine  | Vaccine | active | 2024-12 | eu | hl7 | atc sct |
hl7.fhir.us.davinci-drug-formulary | R4 | BenefitCostTypeVS  | Benefit type of cost | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-drug-formulary | R4 | CoinsuranceOptionVS  | Qualifier for coinsurance rate | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-drug-formulary | R4 | CopayOptionVS  | Qualifier of copay amount | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-drug-formulary | R4 | DrugTierVS  | Drug tier of medication in health plan | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-drug-formulary | R4 | InsuranceItemTypeVS  | Insurance item type | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-drug-formulary | R4 | NonPackSemanticDrugVS  | Semantic Drug Codes | active | 2024-12 | us | hl7 | rx |
hl7.fhir.us.davinci-drug-formulary | R4 | PharmacyBenefitTypeVS  | Pharmacy benefit types | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-drug-formulary | R4 | PlanContactTypeVS  | Type of plan contact | active | 2024-12 | us | hl7 | fhir tho |
hl7.fhir.us.davinci-drug-formulary | R4 | SemanticDrugFormGroupVS  | Semantic Drug Form Group Codes | active | 2024-12 | us | hl7 | rx |
hl7.fhir.us.davinci-drug-formulary | R4 | SemanticDrugVS  | Semantic Drug Codes | active | 2024-12 | us | hl7 | fhir rx |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/acc-patient-occupation-code  | ACC Patient Occupation | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nz-citizenship-status-code  | NZ Citizenship status | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/coverage-category-code  | Coverage Category | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/coverage-type-code  | Coverage Type | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/funded-programme-code  | Funded Programme | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/information-source-code  | Information Source | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/maori-descent  | Māori Descent | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nhi-use-code  | Valid use values for NHI | active | 2024-11 | us | hl7 | fhir |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/nz-residency-code  | NZ Residency status | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/pho-code  | PHO | active | 2024-11 | us | hl7 | |
fhir.org.nz.ig.base | R4 | https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-registration-status-code  | Registration Status of Practitioners | active | 2024-11 | us | hl7 | |
hl7.fhir.cl.minsal.tei | R4 | CodigoExamen  | Códigos de Examenes | active | 2022-01 | cl | hl7 | loinc |
hl7.fhir.cl.minsal.tei | R4 | PueblosOriginariosVS  | Pueblos Originarios de Chile | draft | 2024-10 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | TipoDeObservacion  | Tipo de Observación | active | 2022-01 | cl | hl7 | internal sct loinc |
hl7.fhir.cl.minsal.tei | R4 | VSConsecuenciaAtencionCodigo  | Consecuencia Atención Codigo | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSDerivadoParaCodigo  | Derivado Para | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSDestinoReferenciaCodigo  | Destino Referencia Codigo | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSEspecialidadBioqca  | Especialidades y Subespecialidades Bioquímicas | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSEspecialidadFarma  | Especialidades Farmaceúticas o Química Farmaceúticas | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSEspecialidadMed  | EspecialidadMed | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSEspecialidadOdont  | Especialidades Odontológicas | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSEstablecimientoDestino  | Establecimiento Destino Codigo | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSEstadoCivil  | EstadoCivil | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSEstadoInterconsulta  | Estado Interconsulta | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSIdentificadorPrestador  | IdentificadorPrestador | active | 2023-01 | cl | hl7 | |
hl7.fhir.cl.minsal.tei | R4 | VSIndicecomorbilidad  | Indice Comorbilidad | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSMediodeContacto  | Medio Notificación | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSModalidadAtencionCodigo  | Modalidad Atencion Codigo | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSMotivoCierreInterconsulta  | Motivo Cierre Interconsulta | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSMotivoNoContactabilidad  | Motivo No Contactabilidad | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSMotivoNoPertinenciaCodigo  | Motivo No Pertinencia Codigo | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSPertinenciaInterconsulta  | Pertinencia Interconsulta | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSPractitionerTipoRolLE  | Rol de profesionales | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSReligion  | Religion | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSServicioRequerido  | Servicio Requerido | active | 2023-01 | cl | hl7 | sct |
hl7.fhir.cl.minsal.tei | R4 | VSTerminologiasDiag  | TerminologiasDiag | active | 2023-01 | cl | hl7 | sct icd |
hl7.fhir.cl.minsal.tei | R4 | VSTipoConsulta  | Tipo Consulta | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSTipoEventoLE  | Tipo de Evento | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSTituloProfesional  | TituloProfesional | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VSorigenInterconsulta  | Origen Interconsulta | active | 2023-01 | cl | hl7 | internal |
hl7.fhir.cl.minsal.tei | R4 | VsEspecialidadDest  | Especialidad de Destino | active | 2023-01 | cl | hl7 | internal |
jembi.starter.ig | R4 | art-follow-up-status-value-set  | Follow Up Status | active | 2024-12 | uv | | sct loinc |
jembi.starter.ig | R4 | arv-treatment-value-set  | ARV Drugs | active | 2024-12 | uv | | loinc |
jembi.starter.ig | R4 | breastfeeding-status-value-set  | Breastfeeding Status | active | 2024-12 | uv | | loinc |
jembi.starter.ig | R4 | hiv-test-results-value-set  | HIV Test Results | active | 2024-12 | uv | | loinc |
jembi.starter.ig | R4 | hiv-test-type-value-set  | HIV Test Types | active | 2024-12 | uv | | loinc |
jembi.starter.ig | R4 | vs-marital-status  | Marital Status | active | 2024-12 | uv | | internal |
jembi.starter.ig | R4 | yes-no-value-set  | Yes/No | active | 2024-12 | uv | | internal |
hl7.fhir.us.directory-query | R4 | AcceptingPatientsVS  | Accepting Patients Codes Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | AccessibilityVS  | Accessibility Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | ConsentVS  | National Directory Consent Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | DeliveryMethodVS  | Delivery Methods Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | EndpointConnectionTypeVS  | Endpoint Connection Types Value Set | active | 2022-12 | us | hl7 | fhir tho |
hl7.fhir.us.directory-query | R4 | EndpointPayloadTypeVS  | Endpoint Payload Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | EndpointTypeVS  | Endpoint Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | EndpointUsecaseVS  | Endpoint Usecases Value Set | active | 2022-12 | us | hl7 | tho |
hl7.fhir.us.directory-query | R4 | HealthcareServiceCategoryVS  | Healthcare Service Category Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | HealthcareServiceTypeVS  | HealthcareService Type Value Set | active | 2022-12 | us | hl7 | tho |
hl7.fhir.us.directory-query | R4 | IdentifierStatusVS  | Identifier Status Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | IgTypeVS  | IG Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | IndividualAndGroupSpecialtiesVS  | Individual and Group Specialties | active | 2022-12 | us | hl7 | nucc |
hl7.fhir.us.directory-query | R4 | IndividualSpecialtyAndDegreeLicenseCertificateVS  | Individual Specialties, Degrees, Licenses, and Certificates Value Set | active | 2022-12 | us | hl7 | tho |
hl7.fhir.us.directory-query | R4 | InsurancePlanTypeVS  | Insurance Plan Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | InsuranceProductTypeVS  | Insurance Product Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | LanguageProficiencyVS  | Language Proficiency Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | MinEndpointConnectionTypeVS  | Minimum Endpoint Connection Types Value Set | active | 2022-12 | us | hl7 | fhir tho |
hl7.fhir.us.directory-query | R4 | NetworkTypeVS  | Network Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | NonIndividualSpecialtiesVS  | Non-Individual Specialties | active | 2022-12 | us | hl7 | nucc |
hl7.fhir.us.directory-query | R4 | NonIndividualSpecialtyAndDegreeLicenseCertificateVS  | Non-Individual Specialties, Degrees, Licenses, and Certificates Value Set | active | 2022-12 | us | hl7 | fhir tho |
hl7.fhir.us.directory-query | R4 | OrgAliasTypeVS  | Organization Alias Typ Value Sete | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | OrgTypeVS  | Organization Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | OrganizationAffiliationRoleVS  | OrganizationAffiliation Roles | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | PractitionerRoleVS  | PractitionerRole Code Value Set | active | 2022-12 | us | hl7 | fhir tho |
hl7.fhir.us.directory-query | R4 | QualificationStatusVS  | Qualification Status Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | SpecialtiesVS  | Specialties Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | SpecialtyAndDegreeLicenseCertificateVS  | Specialties, Degrees, Licenses, and Certificates Value Set | active | 2022-12 | us | hl7 | fhir tho |
hl7.fhir.us.directory-query | R4 | TrustFrameworkTypeVS  | Trust Framework Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | ValidationProcessVS  | Validation Type Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.directory-query | R4 | VirtualModalitiesVS  | Virtual Modalities Value Set | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-alerts | R4 | notification-admit-event  | Da Vinci Notification Admit Event ValueSet | active | 2019-07 | us | hl7 | fhir |
hl7.fhir.us.davinci-alerts | R4 | notification-discharge-event  | Da Vinci Notification Discharge Event ValueSet | active | 2019-07 | us | hl7 | fhir |
hl7.fhir.us.davinci-alerts | R4 | notification-event  | Da Vinci Notification Event ValueSet | active | 2019-07 | us | hl7 | fhir |
hl7.fhir.us.davinci-alerts | R4 | notification-transfer-event  | Da Vinci Notification Transfer Event ValueSet | active | 2019-07 | us | hl7 | fhir |
hl7.fhir.uv.application-feature | R5 | capability-feature-value-vs  | Capability Feature Value VS | active | 2024-11 | uv | hl7 | fhir |
hl7.fhir.uv.application-feature | R5 | capability-feature-vs  | Capability Feature VS | active | 2024-11 | uv | hl7 | fhir |
hl7.fhir.uv.application-feature | R5 | processing-status-vs  | Processing Status Value VS | active | 2020-09 | uv | hl7 | fhir |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-brachytherapy-applicator-type-vs  | Brachytherapy Applicator Type Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-brachytherapy-device-type-vs  | Brachytherapy Device Type Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-disease-progression-qualifier-vs  | Disease Progression Qualifier Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-image-guided-radiotherapy-energy-unit-vs  | Image Guided Radiotherapy Energy Unit Value Set | draft | 2024-12 | us | hl7 | ucum |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-image-guided-radiotherapy-modality-vs  | Image Guided Radiotherapy Modality Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-intrafraction-verification-procedure-vs  | Intrafraction Verification Procedure Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-intrafraction-verification-qualifier-vs  | Intrafraction Verification Procedure Qualifier Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-adverse-event-termVS  | Adverse Event Terms Value Set | active | 2024-12 | us | hl7 | ncit tho |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-category-vs  | Radiotherapy Category Code Max Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-energy-unit-vs  | Radiotherapy Energy Unit Value Set | draft | 2024-12 | us | hl7 | ucum |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs  | Radiotherapy Free-Breathing Motion Management Technique Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-isotope-vs  | Radiotherapy Isotope Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-reason-for-revision-or-adaptation-vs  | Radiotherapy Reason for Revision or Adaptation Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-respiratory-motion-management-vs  | Radiotherapy Respiratory Motion Management Value Set | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.davinci-pcde | R4 | PCDEPlanAction  | PCDE Plan Action | draft | 2022-08 | us | hl7 | cpt oid ndc |
hl7.fhir.us.davinci-pcde | R4 | PCDEPlanActionReason  | PCDE Plan Action Reason | draft | 2022-08 | us | hl7 | icd |
hl7.fhir.us.davinci-pcde | R4 | PCDESectionCode  | PCDE Document Section Codes | draft | 2022-08 | us | hl7 | fhir |
hl7.fhir.us.davinci-vbpr | R4 | hcplan-framework  | HCPLAN Framework Categories | active | 2024-06 | us | hl7 | tho |
hl7.fhir.us.davinci-vbpr | R4 | lob  | Line of Business Value Set | active | 2024-06 | us | hl7 | |
hl7.fhir.us.davinci-vbpr | R4 | measure-contractual-status  | Measure Contractual Status | active | 2024-06 | us | hl7 | fhir |
hl7.fhir.us.davinci-vbpr | R4 | measure-stratifier-example  | Measure Stratifier Example | active | 2024-06 | us | hl7 | fhir |
hl7.fhir.us.davinci-vbpr | R4 | threshold-type  | Threshold Type | active | 2024-06 | us | hl7 | fhir |
hl7.fhir.us.davinci-vbpr | R4 | vbp-cohort  | Cohort | active | 2024-06 | us | hl7 | fhir |
hl7.fhir.us.davinci-vbpr | R4 | vbp-incentive  | Incentive | active | 2024-06 | us | hl7 | fhir |
hl7.fhir.us.davinci-vbpr | R4 | vbp-measure-population  | VBP Measure Population Type | active | 2024-06 | us | hl7 | fhir tho |
hl7.fhir.us.davinci-vbpr | R4 | vbp-payment-stream  | Payment Stream Value Set | active | 2024-06 | us | hl7 | fhir |
hl7.fhir.us.davinci-vbpr | R4 | vbp-performance-metric  | Performance Metric | active | 2024-06 | us | hl7 | fhir |
hl7.fhir.vn.core | R4 | http://loinc.org/vs/LL2201-3  | LOINC® LL2201-3 - ValueSet về tình trạng hút thuốc | active | 2024-10 | vn | hl7 | loinc |
hl7.fhir.vn.core | R4 | http://loinc.org/vs/LL3639-3  | LOINC® LL3639-3 - ValueSet về trạng thái lây nhiễm | active | 2024-10 | vn | hl7 | loinc |
hl7.fhir.vn.core | R4 | http://loinc.org/vs/LL3976-9  | LOINC® LL3976-9 - ValueSet về tần suất hút thuốc | active | 2024-10 | vn | hl7 | loinc |
hl7.fhir.vn.core | R4 | http://loinc.org/vs/LL940-8  | LOINC® LL940-8 - ValueSet về tình trạng tiêm chủng | active | 2024-10 | vn | hl7 | loinc |
hl7.fhir.vn.core | R4 | http://hl7.org/fhir/ValueSet/observation-codes  | LOINC Codes | draft | 2019-11 | vn | hl7 | loinc |
hl7.fhir.vn.core | R4 | patient-history-social-factor-type  | ValueSet dành cho loại tiền sử bệnh lý và đặc điểm xã hội | active | 2024-10 | vn | hl7 | loinc |
hl7.fhir.vn.core | R4 | physical-exam-type  | ValueSet dành cho loại thăm, khám lâm sàng | active | 2024-10 | vn | hl7 | loinc |
hl7.fhir.vn.core | R4 | snomedCT-additional-dosage-instruction  | ValueSet dành cho Các chỉ dẫn dùng thuốc (bổ sung) (SNOMED CT) | draft | 2020-12 | vn | hl7 | sct |
hl7.fhir.vn.core | R4 | snomedCT-anatomical-body-structure  | ValueSet dành cho Vị trí cơ thể theo giải phẫu học (SNOMED CT) | draft | 2020-12 | vn | hl7 | sct |
hl7.fhir.vn.core | R4 | snomedCT-clinical-finding  | ValueSet dành cho Các thông tin thăm, khám lâm sàng (SNOMED CT) | draft | 2020-12 | vn | hl7 | sct |
hl7.fhir.vn.core | R4 | snomedCT-dosage-administration-route  | ValueSet dành cho Đường dùng thuốc (SNOMED CT) | draft | 2020-12 | vn | hl7 | sct |
hl7.fhir.vn.core | R4 | vaccine-code  | ValueSet dành cho Vaccine Code | active | 2020-12 | vn | hl7 | atc cvx sct |
hl7.fhir.vn.core | R4 | vn-core-administrative-address  | ValueSet dành cho Thông tin địa danh hành chính | active | 2020-12 | vn | hl7 | internal |
hl7.fhir.vn.core | R4 | vn-core-condition-code  | ValueSet dành cho Mã bệnh tật | active | 2020-12 | vn | hl7 | sct icd |
hl7.fhir.vn.core | R4 | vn-core-diagnosticreport-code  | ValueSet for Diagnostic Report Code | draft | 2020-12 | vn | hl7 | loinc |
hl7.fhir.vn.core | R4 | vn-core-education-level  | ValueSet dành cho Thông tin trình độ học vấn | active | 2020-12 | vn | hl7 | internal |
hl7.fhir.vn.core | R4 | vn-core-ethic  | ValueSet dành cho Thông tin tôn giáo | active | 2020-12 | vn | hl7 | internal |
hl7.fhir.vn.core | R4 | vn-core-observation-smokingstatus  | ValueSet dành cho Tình trạng hút thuốc lá (SNOMED CT) | active | 2020-12 | vn | hl7 | sct |
hl7.fhir.vn.core | R4 | vn-core-occupation  | ValueSet dành cho Thông tin nghề nghiệp | active | 2020-12 | vn | hl7 | internal sct |
hl7.fhir.vn.core | R4 | vn-core-race  | ValueSet dành cho Thông tin dân tộc | active | 2020-12 | vn | hl7 | internal |
hl7.fhir.vn.core | R4 | vn-medication-code  | ValueSet dành cho Mã dược phẩm | draft | 2020-12 | vn | hl7 | internal sct rx |
hl7.fhir.vn.core | R4 | vn-procedure-code  | ValueSet dành cho Mã dịch vụ kỹ thuật | draft | 2020-12 | vn | hl7 | internal sct cpt tho |
hl7.fhir.us.breast-radiology | R4 | AsymmetryAbnormalityTypeVS  | Asymmetry Abnormality Type ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | BreastAssessmentCategoryVS  | Breast Assessment Category ValueSet | active | 2022-12 | us | hl7 | fhir sct |
hl7.fhir.us.breast-radiology | R4 | BreastImagingReportTypesVS  | Breast Imaging Report Types ValueSet | active | 2022-12 | us | hl7 | loinc |
hl7.fhir.us.breast-radiology | R4 | CalcificationDistributionVS  | CalcificationDistribution ValueSet | active | 2022-12 | us | hl7 | sct |
hl7.fhir.us.breast-radiology | R4 | ConsistentWithQualifierVS  | ConsistentWith Qualifier ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | ConsistentWithVS  | ConsistentWith ValueSet | active | 2022-12 | us | hl7 | sct |
hl7.fhir.us.breast-radiology | R4 | CorrespondsWithVS  | CorrespondsWith ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | DensityAbnormalityTypeVS  | Density Abnormality Type ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | DuctAbnormalityTypeVS  | Duct Abnormality Type ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | FibroAdenomaAbnormalityTypeVS  | FibroAdenoma Abnormality Type ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | ForeignObjectAbnormalityTypeVS  | Foreign Object Abnormality Type ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | LymphNodeAbnormalityTypeVS  | Lymph Node Type ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | NotPreviouslySeenVS  | NotPreviouslySeen ValueSet | active | 2022-12 | us | hl7 | sct |
hl7.fhir.us.breast-radiology | R4 | ObservedChangesVS  | ObservedChanges ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | PreviouslyDemonstratedByVS  | PreviouslyDemonstratedBy ValueSet | active | 2022-12 | us | hl7 | sct |
hl7.fhir.us.breast-radiology | R4 | ServiceRecommendationsVS  | ServiceRecommendations ValueSet | active | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1556-presence  | RDE1556 Presence | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1557-side  | RDE1557 Side | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1558-location  | RDE1558 Location | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1559-depth  | RDE1559 Depth | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1560-breast-body-landmark  | RDE1560 Breast body landmark | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1562-laterality-from-landmark  | RDE1562 Laterality from landmark | draft | 2022-10 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1563-quadrant  | RDE1563 Quadrant | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1564-region  | RDE1564 Region | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1565-type  | RDE1565 Type | draft | 2022-10 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1568-distribution  | RDE1568 Distribution | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1571-associated-features  | RDE1571 Associated features | draft | 2022-11 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1576-shape  | RDE1576 Shape | draft | 2022-11 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1577-type  | RDE1577 Type | draft | 2022-10 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1578-density  | RDE1578 Density | draft | 2022-10 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1579-margin  | RDE1579 Margin | draft | 2022-10 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1580-orientation  | RDE1580 Orientation | draft | 2022-10 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1586-assessment-category  | RDE1586 Assessment category | draft | 2022-11 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1587-breast-composition-category  | RDE1587 Breast composition category | draft | 2022-11 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1588-breast-laterality  | RDE1588 Breast laterality | draft | 2022-11 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1589-implant-presence  | RDE1589 Implant presence | draft | 2022-11 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1590-prior-mastectomy  | RDE1590 Prior mastectomy | draft | 2022-11 | us | hl7 | fhir |
hl7.fhir.us.breast-radiology | R4 | rde1602-type  | RDE1602 Type | draft | 2022-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | FDANationalDrugCode  | FDA National Drug Code (NDC) | active | 2024-12 | us | hl7 | ndc |
hl7.fhir.us.davinci-pdex | R4 | MtlsObjectTypeVS  | mTLS Signed Object Types | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | OrgTypeVS  | Organization Type VS | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | PDexAdjudication  | PDex Adjudication | active | 2024-12 | us | hl7 | fhir tho |
hl7.fhir.us.davinci-pdex | R4 | PDexAdjudicationCategoryDiscriminator  | PDex Adjudication Category Discriminator | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | PDexMultiMemberMatchResultVS  | PDex Multi-Member Match Result Value Set | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | PDexPAInstitutionalProcedureCodes  | Procedure Codes - AMA CPT - CMS HCPCS - CMS HIPPS | active | 2024-12 | us | hl7 | cpt cms tho |
hl7.fhir.us.davinci-pdex | R4 | PDexPAInstitutionalProcedureCodesVS  | Prior Authorization Procedure Codes - AMA CPT - CMS HCPCS - CMS HIPPS | active | 2024-12 | us | hl7 | cpt cms tho |
hl7.fhir.us.davinci-pdex | R4 | PDexPayerBenefitPaymentStatus  | PDex Payer Benefit Payment Status | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | PDexSupportingInfoType  | PDex SupportingInfo Type | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | PriorAuthServiceTypeCodes  | Prior Authorization Service Type Codes (X12) | active | 2024-12 | us | hl7 | x12 |
hl7.fhir.us.davinci-pdex | R4 | PriorAuthorizationAmounts  | Prior Authorization value categories | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | ProvenanceAgentType  | Provenance Agent Type | active | 2024-12 | us | hl7 | fhir tho |
hl7.fhir.us.davinci-pdex | R4 | ProvenancePayerSourceFormat  | Payer source of data | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex | R4 | X12278ReviewDecisionReasonCode  | X12 278 Review Decision Reason Codes | active | 2024-12 | us | hl7 | x12 |
hl7.fhir.us.davinci-pdex | R4 | X12ClaimAdjustmentReasonCodesCMSRemittanceAdviceRemarkCodes  | X12 Claim Adjustment Reason Codes - Remittance Advice Remark Codes | active | 2024-12 | us | hl7 | x12 |
hl7.fhir.uv.pocd | R4 | 11073MDC-dimension  | MDC Unit of Measurement | draft | 2021-07 | uv | hl7 | iso |
hl7.fhir.uv.pocd | R4 | 11073MDC-metric  | MDC Metric nomenclature | draft | 2021-07 | uv | hl7 | iso |
hl7.fhir.uv.pocd | R4 | 11073MDC-object  | MDC Object infrastructure and Device nomenclature | draft | 2021-07 | uv | hl7 | iso |
hl7.fhir.uv.pocd | R4 | kind-of-relation  | Kind | draft | 2020-05 | uv | hl7 | fhir |
hl7.fhir.uv.pocd | R4 | metric-availability  | Metric Availability | draft | 2020-12 | uv | hl7 | fhir |
hl7.fhir.uv.pocd | R4 | observation-interpretation  | Observation interpretation codes | draft | 2019-09 | uv | hl7 | fhir tho |
hl7.fhir.uv.pocd | R4 | operating-mode  | Operating Mode | draft | 2020-05 | uv | hl7 | fhir |
hl7.fhir.uv.pocd | R4 | safety  | Safety | draft | 2020-05 | uv | hl7 | fhir |
ch.fhir.ig.ch-ems | R4 | IVR-VS-InfectPersPrecaution  | IVR valueset infectiontransport precaution personnel | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-NACA  | IVR valueset NACA | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-ZUB  | IVR valueset status change | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-actRecovAid  | IVR valueset Recovery Aid (.143.11.3) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-actRespiOwner  | IVR valueset owner (.143.11.6) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-airway  | IVR valueset airway (143.11.2) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-allergy  | IVR valueset allergy (.143.11.7) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-ambulanceType  | IVR Valueset ambulance type (143.11.28) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-bedding  | IVR valueset transport bedding (.143.11.17) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-coldExposure  | IVR valueset cold exposure (.143.11.50) | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-deathManner  | IVR valueset manner of death (.143.11.41) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-diagType  | IVR valueset diagnosis type (.143.11.16) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-diagnosis  | IVR Valueset diagnosis (.143.11.20) | draft | 2024-10 | ch | hl7 | icd |
ch.fhir.ig.ch-ems | R4 | IVR-VS-emergDoctSystem  | IVR valueset mission Emergency doctor system (.143.11.12) | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-event  | IVR valueset event (.143.11.15) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-eyeForm  | IVR valueset eye Form (.143.11.43) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-findingsAirway  | IVR valueset findings airway (.143.11.39) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-formation  | IVR valueset formation (.143.11.9) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcs-augenoeffnung  | IVR valueset GCS Augenoeffnung (143.11.34) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcsMotoric  | IVR valueset GCS motorische Reaktion (.143.11.35) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcsVerbal  | IVR valueset GCS Verbale Kommunikation(.143.11.36) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-heatExposure  | IVR valueset heat exposure (.143.11.51) | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-hospitalPriority  | IVR valueset priority hospital | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-idMedium  | IVR valueset identification medium (.143.11.30) | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-idSource  | IVR valueset identification source (143.11.29) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-intensity  | IVR valueset intensity (.143.11.27) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-location  | IVR valueset location (.143.11.23) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-locationType  | IVR valueset location Type (.143.11.42) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-missionTimeRole  | IVR valueset role mission time (.143.11.10) | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-missionType  | IVR valueset mission type (.143.11.11) | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-offender  | IVR valueset offender (143.11.24) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-patient  | IVR valueset patient | draft | 2024-10 | ch | hl7 | sct loinc |
ch.fhir.ig.ch-ems | R4 | IVR-VS-personRole  | IVR valueset role (.143.11.21) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-preTreatType  | IVR valueset pre-treatment type (.143.11.13) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-preTreatment  | IVR valueset pre-treatment (.143.11.14) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-pressureMethod  | IVR valueset blood pressure method (.143.11.47) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-procAirType  | IVR valueset procedure airway type (.143.11.40) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-pulesResult  | IVR valueset pulse result (.143.11.49) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-pulseMethod  | IVR valueset pulse method (.143.11.48) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-respirationObservation  | IVR valueset Observation Respiration (.143.11.22) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-result  | IVR valueset result (.143.11.44) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-sections  | IVR valueset sections | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-sex  | IVR Valueset sex (.143.11.31) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-size  | IVR Valueset size | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-symptom  | IVR valueset symptom (.143.11.38) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-teamRole  | IVR valueset role team (.143.11.8) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-transDesinfection  | IVR valueset unit desinfection | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-transReason  | IVR valueset transport reason (.143.11.32) | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-urgency-adequate  | IVR valueset urgency adequate (143.11.37) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-urgency  | IVR valueset urgency | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-valTxpe  | IVR valueset valuables type (.143.11.33) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-ventilation  | IVR valueset ventilation (.143.11.46) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | IVR-VS-vigilanzAvpu  | IVR vigilanz (AVPU) | draft | 2024-10 | ch | hl7 | oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-violenceForm  | IVR valueset form of violence (143.11.25) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-violenceResult  | IVR valueset result of violence (.143.11.26) | draft | 2024-10 | ch | hl7 | sct oid |
ch.fhir.ig.ch-ems | R4 | IVR-VS-woundTreat  | IVR valueset wound treatment (.143.11.45) | draft | 2024-10 | ch | hl7 | sct |
ch.fhir.ig.ch-ems | R4 | yes-no-unknown  | Yes/No/Unknown | active | 2020-05 | ch | hl7 | sct |
hl7.fhir.us.pacio-pfe | R4 | pfe-body-structures-vs  | Personal Functioning and Engagement Body Structures Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-category-vs  | Personal Functioning and Engagement Category Value Set | active | 2024-08 | us | hl7 | fhir |
hl7.fhir.us.pacio-pfe | R4 | pfe-communication-vs  | Personal Functioning and Engagement Communication Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-domestic-life-vs  | Personal Functioning and Engagement Domestic Life Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-example-obs-vs  | Personal Functioning and Engagement Example Observations Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-functions-of-digestive-vs  | Personal Functioning and Engagement Functions Of Digestive, Metabolic, and Endocrine Systems Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-genitourinary-vs  | Personal Functioning and Engagement Genitourinary and Reproductive Functions Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-goals-mobility-vs  | Personal Functioning and Engagement Goals Mobility Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-goals-panel-vs  | Personal Functioning and Engagement Goals Panel Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-goals-self-care-vs  | Personal Functioning and Engagement Goals Self-Care Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-learning-and-applying-knowledge-vs  | Personal Functioning and Engagement Learning and Applying Knowledge Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-mental-functions-vs  | Personal Functioning and Engagement Mental Functions Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-mobility-vs  | Personal Functioning and Engagement Mobility Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-neuromusculoskeletal-vs  | Personal Functioning and Engagement Neuromusculoskeletal and Movement Related Functions Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-panel-vs  | Personal Functioning and Engagement Panel Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-products-and-technology-vs  | Personal Functioning and Engagement Products and Technology Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-self-care-vs  | Personal Functioning and Engagement Self-Care Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-sensory-functions-pain-clinical-test-vs  | Personal Functioning and Engagement Sensory Functions and Pain Clinical Test Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-sensory-functions-pain-vs  | Personal Functioning and Engagement Sensory Functions and Pain Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-skin-functions-vs  | Personal Functioning and Engagement Functions of Skin and Related Structures Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-structures-voice-and-speech-vs  | Personal Functioning and Engagement Structures Involved in Voice and Speech Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.us.pacio-pfe | R4 | pfe-survey-category-vs  | Personal Functioning and Engagement Survey Value Set | active | 2024-08 | us | hl7 | tho |
hl7.fhir.us.pacio-pfe | R4 | pfe-us-core-category-vs  | Personal Functioning and Engagement US Core Value Set | active | 2024-08 | us | hl7 | fhir |
hl7.fhir.us.pacio-pfe | R4 | pfe-voice-and-speech-vs  | Personal Functioning and Engagement Voice and Speech Functions Value Set | active | 2024-08 | us | hl7 | loinc |
hl7.fhir.eu.hdr | R4 | TNM-M-category-vs  | TNM M Category | draft | 2024-12 | eu | hl7 | internal |
hl7.fhir.eu.hdr | R4 | TNM-M-clinical-category-vs  | Clinical M | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | TNM-M-pathologycal-category-vs  | Pathological M | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | TNM-N-category-vs  | TNM N Category | draft | 2024-12 | eu | hl7 | internal |
hl7.fhir.eu.hdr | R4 | TNM-N-clinical-category-vs  | Clinical N | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | TNM-N-pathological-category-vs  | Pathological N | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | TNM-T-category-vs  | Primary tumor T | draft | 2024-12 | eu | hl7 | internal |
hl7.fhir.eu.hdr | R4 | TNM-T-clinical-category-vs  | Clinical T | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | TNM-T-pathological-category-vs  | Clinical T | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | admission-urgency-eu-hdr  | Admission Urgency Value Set | draft | 2024-12 | eu | hl7 | tho |
hl7.fhir.eu.hdr | R4 | admission-voluntary-status-vs  | Encounter Voluntary Status Value Set | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | allergy-intolerance-eu-hdr  | Allergy Intolerance (with exceptions) | draft | 2024-12 | eu | hl7 | internal fhir |
hl7.fhir.eu.hdr | R4 | allergy-intolerance-substances-eu-hdr  | Allergy Intolerance | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | anthropometric-observation-vs  | Anthropometric Observation Value Set | draft | 2024-12 | eu | hl7 | internal sct |
hl7.fhir.eu.hdr | R4 | assessment-observation-category-vs  | Xpandh Assessment Observation Category | draft | 2024-12 | eu | hl7 | internal |
hl7.fhir.eu.hdr | R4 | bmi-observation-unit-vs  | BMI Observation Unit Value Set | draft | 2024-12 | eu | hl7 | ucum |
hl7.fhir.eu.hdr | R4 | bmi-observation-vs  | BMI Observation Value Set | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | body-height-observation-vs  | Body Height Observation Value Set | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | body-weight-observation-vs  | Body Weight Observation Value Set | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | body-weight-units-vs  | Body Weight Observation Value Set | draft | 2024-12 | eu | hl7 | ucum |
hl7.fhir.eu.hdr | R4 | cancer-stage-grading-vs  | Cancer Stage Grading: Snomed CT | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | cancer-stageGroup-vs  | Cancer Stage Group: SNOMED CT | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | circumference-observation-vs  | Circumference Observation Value Set | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | condition-eu-hdr  | Condition Value Set | draft | 2024-12 | eu | hl7 | sct icd |
hl7.fhir.eu.hdr | R4 | condition-mandatory-eu-hdr  | Mandatory Condition Value Set | draft | 2024-12 | eu | hl7 | internal fhir sct |
hl7.fhir.eu.hdr | R4 | encounter-status-eu-hdr  | In-patient Encounter Type Value Set | draft | 2024-12 | eu | hl7 | fhir |
hl7.fhir.eu.hdr | R4 | functional-assessment-scales-vs  | Xpandh Functional Assessment Scales | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | hdr-encounter-type-eu-hdr  | In-patient Encounter Type Value Set | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | hdr-encounterClass-eu-hdr  | Encounter Class Value Set | draft | 2024-12 | eu | hl7 | tho |
hl7.fhir.eu.hdr | R4 | mcode-observation-codes-distant-metastases-vs  | Observation Codes for Distant Metastases Category | draft | 2024-12 | eu | hl7 | loinc |
hl7.fhir.eu.hdr | R4 | mcode-observation-codes-primary-tumor-vs  | Observation Codes for Primary Tumor Category | draft | 2024-12 | eu | hl7 | loinc |
hl7.fhir.eu.hdr | R4 | mcode-observation-codes-regional-nodes-vs  | Observation Codes for Regional Node Category | draft | 2024-12 | eu | hl7 | loinc |
hl7.fhir.eu.hdr | R4 | medical-devices-eu-hdr  | Medical Devices (SNOMED CT) - Xpandh | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | medical-devices-snomed-absent-unknown-eu-hdr  | Medical Devices - SNOMED CT + Absent/Unknown - IPS | draft | 2024-12 | eu | hl7 | internal fhir |
hl7.fhir.eu.hdr | R4 | poa-indicator-eu-hdr  | Condition Present on Admission (POA) Value Set | draft | 2024-12 | eu | hl7 | sct tho loinc |
hl7.fhir.eu.hdr | R4 | procedure-snomed-eu-hdr  | Procedure codes: Snomed CT | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | procedures-snomed-absent-unknown-eu-hdr  | Procedures - SNOMED CT + Absent/Unknown - IPS | draft | 2024-12 | eu | hl7 | fhir sct |
hl7.fhir.eu.hdr | R4 | skinfold-thickness-units-vs  | Skinfold Thickness Units Value Set | draft | 2024-12 | eu | hl7 | ucum |
hl7.fhir.eu.hdr | R4 | skinfold-thickness-vs  | Skinfold Thickness Value Set | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | treated-problem-eu-hdr  | Treatment Class Value Set | draft | 2024-12 | eu | hl7 | sct |
hl7.fhir.eu.hdr | R4 | vital-signs-observation-vs  | Vital Signs Observation Value Set | draft | 2024-12 | eu | hl7 | internal sct |
hl7.fhir.be.core | R4 | be-civilstate  | BeCivilState | active | 2024-10 | be | hl7 | internal tho |
hl7.fhir.be.core | R4 | be-contactperson  | BeContactPerson | active | 2024-10 | be | hl7 | internal tho |
hl7.fhir.be.core | R4 | be-vs-care-location  | BeVSCareLocation | active | 2021-01 | be | hl7 | internal |
hl7.fhir.be.core | R4 | be-vs-cd-hcparty  | BeVSCdHcParty | draft | 2024-10 | be | hl7 | internal |
hl7.fhir.be.core | R4 | be-vs-gender-at-birth  | List of possible genders at birth in Belgium | draft | 2024-10 | be | hl7 | fhir |
hl7.fhir.be.core | R4 | be-vs-patient-relationship-type  | BeVSPatientRelationshipType | draft | 2021-01 | be | hl7 | sct |
hl7.fhir.us.birthdefectreporting | R4 | ValueSet-admission-status  | Admission Status | draft | 2024-11 | us | hl7 | fhir |
hl7.fhir.us.birthdefectreporting | R4 | ValueSet-discharged-status  | Discharged Status | draft | 2024-11 | us | hl7 | fhir |
hl7.fhir.us.birthdefectreporting | R4 | ValueSet-patient-location-types  | Patient Location Types | draft | 2024-11 | us | hl7 | fhir |
hl7.fhir.us.birthdefectreporting | R4 | ValueSet-units-of-age  | Units of Age | active | 2024-11 | us | hl7 | ucum |
hl7.fhir.us.birthdefectreporting | R4 | bdr-eventtypes  | Birth Defect Report Event Types | active | 2024-11 | us | hl7 | loinc |
hl7.fhir.us.birthdefectreporting | R4 | bdr-procedurelist  | Newborn Procedure List | draft | 2024-11 | us | hl7 | cdc sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.10--20240802091633  | IPS Allergy or Intolerance Conditions | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.12--20170330000000  | ActStatusActiveCompletedAbortedSuspended | draft | 2024-08 | uv | hl7 | tho |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.14--20170401000000  | DRUGActCode | draft | 2024-08 | uv | hl7 | tho |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.2--20161206000000  | Allergy or Intolerance Type | draft | 2024-08 | uv | hl7 | tho oid |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir//ips/ValueSet/pregnancies-summary-uv-ips  | IPS Pregnancies Summary | draft | 2024-08 | uv | hl7 | loinc |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.22--20170502000000  | ActStatusActiveCompletedAbortedCancelled | draft | 2024-08 | uv | hl7 | tho |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.24--20170502000000  | IPS Condition Status Code | draft | 2024-08 | uv | hl7 | fhir |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.27--20170503000000  | Medicine Package | draft | 2024-08 | uv | hl7 | |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/quantityUnits  | Quantity Units | draft | 2024-08 | uv | hl7 | ucum |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/ips/ValueSet/allergy-reaction-uv-ips  | IPS Allergy Reaction | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/strengthNumerator  | Medicine Strength Numerator | draft | 2024-08 | uv | hl7 | ucum |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/strengthDenominator  | Medicine Strength Denominator | draft | 2024-08 | uv | hl7 | ucum |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.37--20170523000000  | IPS Results Organizer | draft | 2024-08 | uv | hl7 | loinc |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/observation-codes-uv-ips  | IPS Results Observation | draft | 2024-08 | uv | hl7 | loinc |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/imaging-observations-uv-ips  | IPS Results Radiology Observation | draft | 2024-08 | uv | hl7 | loinc |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.42--20170524000000  | IPS Allergy Status Code | draft | 2024-08 | uv | hl7 | fhir |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/healthcare-professional-roles-uv-ips  | IPS Healthcare Professional Roles | draft | 2024-08 | uv | hl7 | oid |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/personal-relationship-uv-ips  | IPS Personal Relationship | draft | 2024-08 | uv | hl7 | tho |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/target-site-uv-ips  | IPS Body Site | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://hl7.org/uv/ips/fhir/ValueSet/specimen-type  | IPS Specimen Type | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.57--20171212192725  | Laterality (qualifier) | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.58--20171212193352  | Topographical modifier (qualifier) | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.60--20171214102248  | Allergy-intolerance Criticality | draft | 2024-08 | uv | hl7 | oid |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/absent-or-unknown-devices-uv-ips  | Absent or Unknown Devices | draft | 2024-08 | uv | hl7 | fhir |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.62--20180207120421  | IPS Allergy Verification Status | draft | 2024-08 | uv | hl7 | fhir |
hl7.cda.uv.ips | R4 | http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-uv-ips  | IPS Allergy or Intolerance Substances | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.66--20240802105026  | IPS Results Radiology Textual Observations | draft | 2024-08 | uv | hl7 | sct loinc dcm |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.71--20240802094107  | IPS Medications Products | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.72--20240802094107  | IPS Pregnancy Expected Delivery Date Method | draft | 2024-08 | uv | hl7 | loinc |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.73--20240802094107  | IPS Problems | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.76--20240802105320  | IPS Results Specimen Collection Method | draft | 2024-08 | uv | hl7 | sct |
hl7.cda.uv.ips | R4 | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.8--20170329000000  | IPS Condition Verification Status | draft | 2024-08 | uv | hl7 | fhir |
moh.gov.rw.hiv | R5 | vs-arv-adherence  | Adherence to ARV Treatment | active | 2024-10 | uv | | loinc |
moh.gov.rw.hiv | R5 | vs-arv-regimen  | ARV Regimen | active | 2024-10 | uv | | sct |
moh.gov.rw.hiv | R5 | vs-patient-consent-for-sms-notifications  | Patient Consent for SMS Notifications | active | 2024-10 | uv | | sct |
moh.gov.rw.hiv | R5 | vs-patient-pregnant  | Patient Pregnant | active | 2024-10 | uv | | sct |
moh.gov.rw.hiv | R5 | vs-reason-arv-regimen-change  | Reasons for ARV Regimen Change | active | 2024-10 | uv | | sct |
moh.gov.rw.hiv | R5 | vs-reason-for-assessment  | Reason for Assessment or Test Not Performed | active | 2024-10 | uv | | internal sct |
moh.gov.rw.hiv | R5 | vs-reason-sample-cancelled-or-rejected  | Lab Order Reasons For Cancelling/Rejecting Lab Order | active | 2024-10 | uv | | internal sct |
moh.gov.rw.hiv | R5 | vs-specimen-type  | Specimen Type Used In Viral Load testing | active | 2024-10 | uv | | sct |
moh.gov.rw.hiv | R5 | vs-test-types  | HIV Test Types | active | 2024-10 | uv | | loinc |
moh.gov.rw.hiv | R5 | vs-vl-suppression  | Viral Load Suppressions Status | active | 2024-10 | uv | | sct |
hl7.fhir.cl.IPSFalp | R4 | VSSeccionesDoc  | VSSeccionesD | active | 2024-12 | cl | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-additional-monitoring-indicator  | CH SMC- Additional Monitoring Indicator | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-attached-document-type  | CH SMC - Attached Document Type | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-authorisation-category  | CH SMC - Authorisation Category | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-authorisation-status  | CH SMC - Authorisation Status | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-authorised-pharmaceutical-dose-form  | CH SMC - Authorised Pharmaceutical Dose Form | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-ingredient-role  | CH SMC - Ingredient Role | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-legal-status-of-supply  | CH SMC - Legal Status of Supply | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-marketing-status  | CH SMC - Marketing Status | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-pediatric-use-indicator  | CH SMC - Pediatric Use Indicator | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-special-precautions-for-storage  | CH SMC - Special Precautions for Storage | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-substance  | CH SMC - Substance | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-SMC-therapeuticproductcode  | CH SMC - TherapeuticProductcode | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-authorisation-type  | CH - Authorisation Type | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-epl-foph-gamme  | CH EPL - Gamme | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-epl-foph-limitationstatus  | CH EPL - Limitation Status | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-epl-foph-listing-status  | CH EPL - Listing Status | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-epl-foph-other-characteristics-packaged-item  | CH EPL - Other Characteristics Packaged Item | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-epl-foph-pricetype  | CH EPL - Price Type | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-epl-foph-product-type  | CH EPL - Product Type | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-epl-foph-reimbursement-status  | CH EPL - Reimbursement Status | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-epl-foph-type-of-price-change  | CH EPL - Type of Price Change | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-medicinal-product-name-type  | CH - Medicinal Product Name Type | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | ch-other-characteristics-type  | CH - Other Characteristics Type | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-epl | R5 | edqm-combination-packaging  | EDQM - Combination Packaging | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | edqm-combined-pharmaceutical-dose-form  | EDQM - Combined Pharmaceutical Dose Form | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | edqm-combined-term  | EDQM - Combined Term | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | edqm-packaging  | EDQM - Packaging | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | edqm-pharmaceutical-dose-form  | EDQM - Pharmaceutical Dose Form | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | edqm-route-of-administration  | EDQM - Route Of Administration | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | edqm-unit-of-presentation  | EDQM - Unit of Presentation | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | ema-domain  | EMA - Domain | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | ema-intended-effect  | EMA - Intended Effect | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-epl | R5 | ema-shelf-life-type  | EMA - Shelf Life Type | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-lab-report | R4 | ch-lab-bloodgroup-antibody-screen-vs  | CH LAB-Report BloodGroup Antibody Screen Test (LOINC codes) | draft | 2024-05 | ch | hl7 | loinc |
ch.fhir.ig.ch-lab-report | R4 | ch-lab-bloodgroup-antibody-vs  | CH LAB-Report BloodGroup Antibody Result (SNOMED CT coded substances) | active | 2024-05 | ch | hl7 | sct |
ch.fhir.ig.ch-lab-report | R4 | ch-lab-bloodgroup-immuno-hematology-vs  | CH LAB-Report BloodGroup Immunohematology Tests (SNOMED CT coded procedures) | draft | 2024-05 | ch | hl7 | sct |
ch.fhir.ig.ch-lab-report | R4 | observation-code-cdk-epi-2009  | CH LAB-Report Codes for eGFR in CKD-EPI | draft | 2024-11 | ch | hl7 | loinc |
ch.fhir.ig.ch-lab-report | R4 | observation-code-cdk-epi-2021  | CH LAB-Report Codes for eGFR in CKD-EPI 2021 | draft | 2024-11 | ch | hl7 | loinc |
ch.fhir.ig.ch-lab-report | R4 | observation-code-entsvol-ratio  | CH LAB-Report Codes for Erythrocyte Distribuiton Width Test | draft | 2024-11 | ch | hl7 | loinc |
ch.fhir.ig.ch-lab-report | R4 | observation-code-mdrd-male-female  | CH LAB-Report Codes for eGFR (MDRD) | draft | 2024-11 | ch | hl7 | loinc |
hl7.fhir.us.registry-protocols | R4 | AbnormalElectrocardiacAssessment  | Abnormal Electrocardiac Assessment | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | Antiarrhythmics  | All Antiarrhythmics | active | 2023-11 | us | hl7 | rx |
hl7.fhir.us.registry-protocols | R4 | ArterialAccessSite  | Arterial Access Site | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | CABG  | Coronary artery bypass grafting | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | CABGIndication  | CABG Indication | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | CABGStatus  | CABG Status | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | CABGType  | Coronary Artery Bypass Graft Type | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | CardiacArrest  | Cardiac Arrest | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | CardiacCTA  | CTA Heart and Coronary arteries | active | 2023-11 | us | hl7 | loinc |
hl7.fhir.us.registry-protocols | R4 | CardiacCTAResults  | Cardiac CTA Results | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | CardiacCatheter  | SNOMED Cardiac Catheters | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | CardiacInstabilityType  | Cardiac Instability Type | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | CardiacRehabilitationReferral  | Cardiac Rehabilitation Referral | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | CardiacValves  | Cardiac Valves | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | CardiovascularTreatmentDecision  | Cardiovascular Treatment Decision Options | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | CerebrovascularDisease  | Cerebrovascular Disease | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | ChestPainSymptomAssessment  | Chest Pain Symptom Assessment | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | ChronicLungDisease  | Chronic Lung Disease | active | 2023-11 | us | hl7 | sct loinc |
hl7.fhir.us.registry-protocols | R4 | ConcomitantProceduresPerformedType  | Concomitant Procedures Performed Type | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | DiabetesMellitus  | Diabetes Mellitus | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | Dyslipidemia  | Dyslipidemia | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAbnormalityType  | Electrocardiac Abnormality Type | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAssessmentMethod  | Electrocardiac Assessment Method | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAssessmentResults  | Electrocardiac Assessment Results | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | FamilyPrematureCAD  | Family History of Premature CAD | active | 2023-11 | us | hl7 | sct loinc |
hl7.fhir.us.registry-protocols | R4 | FirstCardiacArrestRhythm  | First Cardiac Arrest Rhythm | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | FunctionalCapacity  | Functional Capacity | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | GraftVesselCABGVessel  | Graft Vessel CABG Vessel | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | HealthInsurancePaymentSource  | Health Insurance Payment Source | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | HeartFailure  | Heart Failure codes from SNOMED | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | HemodialysisOrPeritonealDialysis  | hemodialysis or peritoneal dialysis | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | Hypertension  | Hypertension | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | HypothermiaInduced  | Induced Hypothermia Codes | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | InterventionTypes  | Intervention Types | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | IntraAndPostEvents  | Cath PCI qualified list of Events | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | LesionComplexity  | Complexity of the Lesion | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | LesionSegmentNumber  | Lesion Segment Number | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | LocationInGraft  | Location in the CABG Graft | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | MechanicalVentricularSupportTiming  | Mechanical Ventricular Support Timing | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | MultivesselProcedureType  | Multi-vessel Procedure Type | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | MyocardialInfarction  | Myocardial Infarction | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | NCDRErrorsVS  | NCDRErrorsVS | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | NewYorkHeartAssociation  | New York Heart Association Assessment Scale | active | 2023-11 | us | hl7 | sct loinc |
hl7.fhir.us.registry-protocols | R4 | NewYorkHeartAssociationAnswers  | New York Heart Association OA Answer List | active | 2023-11 | us | hl7 | loinc |
hl7.fhir.us.registry-protocols | R4 | NonSustainedVentricularTachycardiaType  | Non-Sustained Ventricular Tachycardia Type | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | OrganDonor  | SNOMED Valueset of Organ Donor codes | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | PCIIndications  | Percutaneous Coronary Intervention Indication | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | PCIOperator  | PCI Operator SNOMED codes | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | PCIStatus  | PCI Status Options | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | PackedRedBloodCells  | Packed Red Blood Ceels | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | PatientCenteredReasonforDelay  | Patient Centered Reason for Delay | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | PercutaneousCoronaryIntervention  | PCI | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | PeripheralArterialOcclusiveDisease  | Peripheral Arterial Occlusive Disease | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | PriorCABG  | Prior History of Coronary Artery Bypass Graft | active | 2023-11 | us | hl7 | sct loinc |
hl7.fhir.us.registry-protocols | R4 | PriorDiagnosticCoronaryAngiographyProcedureResults  | Prior Diagnostic Coronary Angiography Procedure Results | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | PriorMyocardialInfarction  | Prior Myocardial Infarction | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | RoseDyspneaQ  | Rose Dyspnea Questions | active | 2023-11 | us | hl7 | loinc |
hl7.fhir.us.registry-protocols | R4 | SEattleAnginaQs  | Seattle Angina Questions | active | 2023-11 | us | hl7 | loinc |
hl7.fhir.us.registry-protocols | R4 | STEMIFirstNoted  | STEMI or STEMI Equivalent First Noted | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | SeattleAnginaAs  | Seattle Angina Answers | active | 2023-11 | us | hl7 | loinc |
hl7.fhir.us.registry-protocols | R4 | SmokingStatus  | Smoking Status | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | StentType  | CathPCI List of Stent Types | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | StressTest  | Cath PCI Selected Stress Test | active | 2023-11 | us | hl7 | loinc |
hl7.fhir.us.registry-protocols | R4 | StressTestResults  | Stress Test Results | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | StressTestRiskExtentofIschemia  | Stress Test Risk/Extent of Ischemia | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | SubmissionType  | Submission Type | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | SurgicalRisk  | SurgicalRisk | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | SyntaxScore  | Syntax Score for the PCI procedure | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | TIMIFlow  | TIMI Flow | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | ValvularDiseaseRegurgitationSeverity  | Valvular Disease Regurgitation Severity | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | ValvularDiseaseStenosisSeverity  | Valvular Disease Stenosis Severity | active | 2023-11 | us | hl7 | fhir |
hl7.fhir.us.registry-protocols | R4 | ValvularRegurgitation  | Valvular Regurgitation | active | 2023-11 | us | hl7 | sct |
hl7.fhir.us.registry-protocols | R4 | ValvularStenosis  | Valvular Stenosis | active | 2023-11 | us | hl7 | loinc |
hl7.fhir.us.registry-protocols | R4 | VentricularSupport  | VentricularSupport | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | VentricularSupportDeviceType  | Ventricular Support Device Type | active | 2023-11 | us | hl7 | fhir sct |
hl7.fhir.us.registry-protocols | R4 | YesNo  | Yes or No | active | 2023-11 | us | hl7 | sct tho |
hl7.fhir.us.registry-protocols | R4 | ncdrq  | All codes used as NCDR questions for CathPCI | active | 2023-11 | us | hl7 | fhir |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-acquisition-modality  | Modality that created the series | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-caveat-condition  | Caveat Condition | active | 2024-11 | ch | hl7 | sct |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-caveat-device  | Caveat Device | active | 2024-11 | ch | hl7 | sct |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-caveat-qualifier-value  | Qualifier Value | active | 2024-11 | ch | hl7 | sct |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-caveat-type  | Type of Caveat | active | 2024-11 | ch | hl7 | sct |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-guidance-for-action  | Guidance for Action | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-imaging-focus  | Imaging Focus | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-imaging-region  | Imaging Region | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-laterality  | Laterality | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-maneuver-type  | Maneuver Type | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-modality-type  | Modality Type | active | 2024-11 | ch | hl7 | |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-order-detail-type  | Type of Order Detail | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-requested-service  | Requested Service | active | 2024-11 | ch | hl7 | internal |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-view-type  | View Type | active | 2024-11 | ch | hl7 | |
my-ig | R4 | https://hl7.pt/fhir/community-health/ValueSet/episode-of-care-status-subset  | Subset of Episode Of Care Status | active | 2024-12 | uv | hl7 | fhir |
hl7.fhir.us.hai | R4 | nhsn-pathogen-ranking  | NHSNPathogenRanking | active | 2023-09 | us | hl7 | sct |
hl7.fhir.us.cardx-htn | R4 | MeasSettingVS  | Measurement Setting value set | draft | 2023-08 | us | hl7 | sct |
hl7.fhir.us.cardx-htn | R4 | MeasurementProtocolVS  | Measurement Protocol value set | draft | 2023-08 | us | hl7 | fhir |
hl7.fhir.us.cardx-htn | R4 | NumericResultIntVS  | Numeric Result Interpretation value set | draft | 2023-08 | us | hl7 | tho |
hl7.fhir.us.cardx-htn | R4 | bodyPositionVS  | Body Position value set | draft | 2023-08 | us | hl7 | sct |
hl7.fhir.us.cardx-htn | R4 | bpMeasMethodVS  | Blood Pressure Measurement Method value set | draft | 2023-08 | us | hl7 | fhir sct |
hl7.fhir.us.cardx-htn | R4 | bpmeasbodylocationprecoord  | Blood Pressure Measurement Body Location Precoordinated value set | draft | 2023-08 | us | hl7 | sct |
hl7.fhir.us.cardx-htn | R4 | exertionPhaseVS  | Exertion Phase value set | draft | 2023-08 | us | hl7 | sct |
hl7.fhir.us.cardx-htn | R4 | heartRateMeasBodyLocationPrecoordVS  | Heart Rate Measurement Body Location Precoordinated value set | draft | 2023-08 | us | hl7 | fhir sct |
hl7.fhir.us.cardx-htn | R4 | heartRateMeasDeviceVS  | Heart Rate Measurement Device value set | draft | 2023-08 | us | hl7 | sct |
hl7.fhir.us.cardx-htn | R4 | heartRateMeasMethodVS  | Heart Rate Measurement Method value set | draft | 2023-08 | us | hl7 | fhir sct |
hl7.fhir.us.cardx-htn | R4 | sleepStatusVS  | Sleep Status value set | draft | 2023-08 | us | hl7 | sct |
tw.gov.mohw.twcore | R4 | category-code-tw  | 臺灣衛福部資訊處類型代碼值集 | active | 2024-08 | tw | national | internal tho |
tw.gov.mohw.twcore | R4 | condition-code-sct-tw  | SNOMED CT診斷代碼值集 | active | 2024-12 | tw | national | sct |
tw.gov.mohw.twcore | R4 | health-professional-sct-tw  | SNOMED CT + 臺灣醫事司醫事人員類別值集 | active | 2022-01 | tw | national | internal sct |
tw.gov.mohw.twcore | R4 | health-professional-tw  | 臺灣醫事司醫事人員類別值集 | active | 2022-01 | tw | national | internal |
tw.gov.mohw.twcore | R4 | icd-10-cm-2014-tw  | 臺灣健保署2014年中文版ICD-10-CM值集 | active | 2014-07 | tw | national | internal |
tw.gov.mohw.twcore | R4 | icd-10-cm-2021-tw  | 臺灣健保署2021年中文版ICD-10-CM值集 | active | 2022-07 | tw | national | internal |
tw.gov.mohw.twcore | R4 | icd-10-cm-2023-tw  | 臺灣健保署2023年中文版ICD-10-CM值集 | active | 2024-11 | tw | national | internal |
tw.gov.mohw.twcore | R4 | icd-10-pcs-2014-tw  | 臺灣健保署2014年中文版ICD-10-PCS值集 | active | 2014-07 | tw | national | internal |
tw.gov.mohw.twcore | R4 | icd-10-pcs-2021-tw  | 臺灣健保署2021年中文版ICD-10-PCS值集 | active | 2022-07 | tw | national | internal |
tw.gov.mohw.twcore | R4 | icd-10-pcs-2023-tw  | 臺灣健保署2023年中文版ICD-10-PCS值集 | active | 2024-11 | tw | national | internal |
tw.gov.mohw.twcore | R4 | icd-9-cm-2001-tw  | 臺灣健保署2001年中文版ICD-9-CM值集 | active | 2023-05 | tw | national | internal |
tw.gov.mohw.twcore | R4 | identifier-type-tw  | IdentifierType + 臺灣衛福部資訊處識別碼類型值集 | active | 2022-07 | tw | national | internal tho |
tw.gov.mohw.twcore | R4 | industry-dgbas-tw  | 行政院主計總處行業分類值集 | active | 2021-01 | tw | national | internal |
tw.gov.mohw.twcore | R4 | laboratory-category-tw  | 臺灣健保署醫療服務給付項目-檢驗值集 | active | 2022-07 | tw | national | internal |
tw.gov.mohw.twcore | R4 | loinc-doc-section-code  | LOINC Code Document Section值集 | active | 2024-06 | tw | national | loinc |
tw.gov.mohw.twcore | R4 | loinc-document-classcodes  | LOINC Document Class值集 | active | 2024-06 | tw | national | loinc |
tw.gov.mohw.twcore | R4 | loinc-observation-code  | LOINC實驗室檢驗檢查值集 | active | 2022-08 | tw | national | loinc |
tw.gov.mohw.twcore | R4 | loinc-pregnancy-intent-code  | LOINC + HL7 NullFlavor妊娠計畫值集 | active | 2024-12 | tw | national | tho loinc |
tw.gov.mohw.twcore | R4 | loinc-survey-codes  | LOINC篩檢與評估值集 | active | 2024-12 | tw | national | loinc |
tw.gov.mohw.twcore | R4 | loinc-type-doc-code  | LOINC Code Document Type值集 | active | 2024-06 | tw | national | loinc |
tw.gov.mohw.twcore | R4 | marital-status-tw  | 臺灣戶政司婚姻狀態值集 | active | 2022-01 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medcation-atc-tw  | 臺灣食藥署藥品藥理治療分類ATC碼值集 | active | 2014-09 | tw | national | atc |
tw.gov.mohw.twcore | R4 | medical-consultation-department-nhi-tw  | 臺灣健保署就醫科別值集 | active | 2024-05 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medical-consultation-department-tw  | 無法對應至SNOMED CT之臺灣健保署就醫科別值集 | active | 2024-05 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medical-department-sct-tw  | 對應至 SNOMED CT之就醫科別 + 診療科別值集 | active | 2024-05 | tw | national | sct |
tw.gov.mohw.twcore | R4 | medical-treatment-department-nhi-tw  | 臺灣健保署診療科別值集 | active | 2024-05 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medical-treatment-department-tw  | 無法對應至SNOMED CT之臺灣健保署診療科別值集 | active | 2024-05 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medication-fda-tw  | 臺灣食藥署藥品及醫療器材代碼值集 | active | 2022-08 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medication-frequency-hl7-tw  | HL7 TimingAbbreviation + 臺灣健保署藥品使用頻率值集 | active | 2024-01 | tw | national | internal tho |
tw.gov.mohw.twcore | R4 | medication-frequency-nhi-tw  | 臺灣健保署藥品使用頻率值集 | active | 2024-05 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medication-nhi-tw  | 臺灣健保署用藥品項代碼值集 | active | 2018-06 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medication-path-sct-tw  | SNOMED CT + 臺灣健保署給藥途徑值集 | active | 2024-01 | tw | national | internal sct |
tw.gov.mohw.twcore | R4 | medication-path-tw  | 臺灣健保署給藥途徑值集 | active | 2022-08 | tw | national | internal |
tw.gov.mohw.twcore | R4 | medication-rxnorm-tw  | RxNorm藥品代碼值集 | active | 2020-11 | tw | national | rx |
tw.gov.mohw.twcore | R4 | narrative-status  | 臺灣衛福部資訊處Narrative狀態值集 | active | 2024-08 | tw | national | fhir |
tw.gov.mohw.twcore | R4 | nhi-medication-ch-herb-tw  | 臺灣健保署中藥用藥品項值集 | active | 2024-06 | tw | national | internal |
tw.gov.mohw.twcore | R4 | observation-clinical-result-category  | 臺灣衛福部資訊處Observation Clinical Result類型值集 | active | 2024-08 | tw | national | tho |
tw.gov.mohw.twcore | R4 | observation-screening-assessment-category  | 臺灣衛福部資訊處Observation Screening Assessment類型值集 | active | 2024-08 | tw | national | internal |
tw.gov.mohw.twcore | R4 | occupation-lia-roc-tw  | 臺灣壽險公會傷害保險個人職業分類表值集 | active | 2023-06 | tw | national | internal |
tw.gov.mohw.twcore | R4 | occupation-mol-tw  | 臺灣勞動部職業標準分類值集 | active | 2010-05 | tw | national | internal |
tw.gov.mohw.twcore | R4 | organization-identifier-tw  | 臺灣醫事司醫事機構代碼值集 | active | 2024-04 | tw | national | internal |
tw.gov.mohw.twcore | R4 | postal-code3-tw  | 臺灣中華郵政3碼郵遞區號值集 | active | 2015-01 | tw | national | internal |
tw.gov.mohw.twcore | R4 | postal-code5-tw  | 臺灣中華郵政5碼郵遞區號值集 | active | 2022-06 | tw | national | internal |
tw.gov.mohw.twcore | R4 | postal-code6-tw  | 臺灣中華郵政6碼郵遞區號值集 | active | 2020-10 | tw | national | internal |
tw.gov.mohw.twcore | R4 | procedure-tw  | 臺灣健保署醫療服務給付項目-處置或手術值集 | active | 2024-05 | tw | national | internal |
tw.gov.mohw.twcore | R4 | provenance-participant-type-hl7-tw  | HL7 Provenance participant type + 臺灣衛福部資訊處Provenance參與類型 | active | 2024-08 | tw | national | internal tho |
tw.gov.mohw.twcore | R4 | serviceRequest-category  | 臺灣衛福部資訊處ServiceRequest類型值集 | active | 2024-08 | tw | national | internal sct |
tw.gov.mohw.twcore | R4 | smoking-status-comprehensive-code  | SNOMED CT 吸菸狀態綜合評估值集 | active | 2024-12 | tw | national | sct |
tw.gov.mohw.twcore | R4 | smoking-status-type-code  | SNOMED CT + LOINC 吸菸狀態種類向值集 | active | 2024-12 | tw | national | sct loinc |
tw.gov.mohw.twcore | R4 | snomed-pregnancy-status-code  | SNOMED CT + HL7 NullFlavor妊娠狀態值集 | active | 2024-12 | tw | national | sct tho |
tw.gov.mohw.twcore | R4 | snomed-sexual-orientation-code  | SNOMED CT + HL7 NullFlavor 性傾向值集 | active | 2024-12 | tw | national | sct tho |
tw.gov.mohw.twcore | R4 | v3-orderableDrugForm  | HL7 OrderableDrugForm藥品劑型值集 | active | 2019-03 | tw | national | tho |
tw.gov.mohw.twcore | R4 | vital-signs-tw  | LOINC生命體徵值集 | active | 2022-08 | tw | national | loinc |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-message-significance-category  | US Public Health ValueSet - Message Significance Category | draft | 2019-11 | us | hl7 | fhir |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-message-types  | US Public Health VaueSet - Message Types | active | 2020-09 | us | hl7 | fhir |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-plandefinition-action  | US Public Health VaueSet - PlanDefinition Action | active | 2020-09 | us | hl7 | fhir |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-pregnancy-status  | US Public Health VaueSet - Pregnancy Status | active | 2018-08 | us | hl7 | vsac tho |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-priority  | US Public Health ValueSet Priority | active | 2021-08 | us | hl7 | fhir |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-report-initiation-type  | US Public Health ValueSet - Report Initiation Type | active | 2022-09 | us | hl7 | fhir |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-triggerdefinition-namedevent  | US Public Health VaueSet - TriggerDefinition NamedEvent | active | 2020-09 | us | hl7 | fhir |
kl.dk.fhir.rehab | R4 | CancellationTypes  | CancellationTypes | active | 2024-10 | dk | | |
kl.dk.fhir.rehab | R4 | CarePlanCategories140  | CarePlanCategories | active | 2024-10 | dk | | |
kl.dk.fhir.rehab | R4 | Conditions140  | §140 tilstande | active | 2024-10 | dk | | oid |
kl.dk.fhir.rehab | R4 | DeliveryTypes140  | DeliveryTypes | active | 2024-10 | dk | | |
kl.dk.fhir.rehab | R4 | EncounterClassCodes  | KontaktKlasseKoder | active | 2024-10 | dk | | tho |
kl.dk.fhir.rehab | R4 | ServiceRequestStatusReasons140  | ServiceRequestStatusReasons | active | 2024-10 | dk | | |
kl.dk.fhir.rehab | R4 | ServiceRequestTypes140  | ServiceRequestTypes | active | 2024-10 | dk | | |
kl.dk.fhir.rehab | R4 | ServiceTypes140  | ServiceTypes | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | BodyheightSCTobservablesChildren  | HøjdeObservationskoderSCT | active | 2024-10 | dk | | sct |
kl.dk.fhir.children | R4 | ChildrenParentRelationshipCodes  | ForældreBarnRelationsKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | CommunicationCodes  | KommunikationKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | EncounterClassCodes  | KontaktKlasseKoder | active | 2024-10 | dk | | tho |
kl.dk.fhir.children | R4 | EncounterTypes  | SundhedsplejeKontaktTyper | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | ExamResults  | UndersøgelsesResultatKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | FeedingResultsChildren  | ResultatkoderSmåbørnMad | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | FindingInformerCodes  | KildeTilOplysningKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | HearingCodes  | HørelseKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | IndicatorCodesChildren  | SundhedsplejeIndikatorkoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | KLHealthNurseConditions  | Sundhedsplejetilstande | active | 2024-10 | dk | | internal |
kl.dk.fhir.children | R4 | KLHealthNurseInterventions  | Sundhedsplejeindsatser | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | MotorFunctionCodes  | MotorikKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | NicotineCodes  | NikotinKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | NutritionCodes  | ErnæringKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | ObservationUnitsWeight  | ObservationsEnhederVægt | active | 2024-10 | dk | | ucum |
kl.dk.fhir.children | R4 | ParentSocialStatusCodes  | ForældresSårbarhedKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | ParentTypes  | ForælderTyper | active | 2024-10 | dk | | tho |
kl.dk.fhir.children | R4 | ParentsMentalCodes  | ForældresPsykiskeTilstandKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | PassiveSmokingCodes  | PassivRygningKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | PhysicalActivityCodes  | FysiskAktiviteteKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | SightCodes  | SynKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | SleepCodes  | SøvnKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | SocialInteractionCodes  | SocialKontaktKoder | active | 2024-10 | dk | | |
kl.dk.fhir.children | R4 | SocialSupportNetworkCodes  | NetværkKoder | active | 2024-10 | dk | | |
hl7.fhir.uv.radiation-dose-summary | R4 | component-radiation-dose-summary-vs  | Radiation Dose Summary component type | draft | 2024-07 | uv | hl7 | sct dcm |
hl7.fhir.uv.radiation-dose-summary | R4 | isotope-rds-vs  | Isotopes Value Set | draft | 2024-07 | uv | hl7 | dcm |
hl7.fhir.uv.radiation-dose-summary | R4 | procedure-reported-type-rds-vs  | Procedure Reported Type Value Set | draft | 2024-07 | uv | hl7 | sct dcm |
hl7.fhir.uv.radiation-dose-summary | R4 | radiopharmaceutical-rds-vs  | Radiopharmaceuticals Value Set | draft | 2024-07 | uv | hl7 | dcm |
hl7.fhir.us.spl | R5 | splDocumentCodes  | SPL Document Codes | active | 2024-12 | us | hl7 | loinc |
hl7.fhir.us.spl | R5 | splSectionCodes  | SPL Section Codes | active | 2024-12 | us | hl7 | loinc |
hl7.fhir.us.spl | R5 | valueset-AllNDCProducts  | All NDC Products | active | 2024-12 | us | hl7 | ndc |
hl7.fhir.us.spl | R5 | valueset-SubmittedMedicinalProductCharacteristicTypes  | SPL Product Characteristic Types ValueSet | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.spl | R5 | valueset-businessOperationQualifiers  | Business Operation Qualifiers | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-establishmentBusinessOperations  | Establishment Business Operations | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-gdufaFacilityBusinessOperationQualifiers  | GDUFA Facility Business Operation Qualifiers | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-gdufaFacilityBusinessOperations  | GDUFA Facility Business Operations | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-genericFacilityMessageTypes  | Generic Facility Message Types | active | 2024-12 | us | hl7 | loinc |
hl7.fhir.us.spl | R5 | valueset-labelerBusinessOperations  | Labeler Business Operations | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-organizationSubmissionMessageTypes  | Organization Submission Message Types | active | 2024-12 | us | hl7 | fhir loinc |
hl7.fhir.us.spl | R5 | valueset-registrantOrganizationTypes  | Registrant Organization Types | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.spl | R5 | valueset-splColor  | SPL Color | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splComboProductType  | SPL Combo Product Type | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splDoseForm  | SPL Dose Form | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splFlavor  | SPL Flavor | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splMarketingCategories  | SPL Marketing Categories | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splMarketingStatuses  | SPL Marketing Statuses ValueSet | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.spl | R5 | valueset-splOperationType  | SPL Operation Type | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splPackageTypes  | SPL Package Types | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splRouteOfAdministration  | SPL Route of Administration | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splShape  | SPL Shape | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-splSpecialMeasures  | SPL Special Measures | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.spl | R5 | valueset-topLevelOrganizationTypes  | Top-Level Organization Types | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-certified-workflow-example  | ValueSet - Certified Workflow example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-cremation-clearance-observations-example  | ValueSet - Cremation Clearance Observations example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-cremation-clearance-signed-example  | ValueSet - Cremation Clearance Signed example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-cremation-clearance-status-example  | ValueSet - Cremation Clearance Status example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-dcr-reason-example  | ValueSet - Death Certificate Review Reason example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-death-certificate-review-observations-example  | ValueSet - Death Certificate Review Observations example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-embalmed-example  | ValueSet - Embalmed example | active | 2024-12 | us | hl7 | sct |
hl7.fhir.us.mdi | R4 | vs-me-cert-affirmation-example  | ValueSet - Medical Examiner Certification Affirmation example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-med-dq-review-example  | ValueSet - Medical Data Quality Review example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-per-dq-review-example  | ValueSet - Personal Data Quality Review example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-registration-example  | Registration example | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-tracking-number-type  | Tracking Number Type | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-apgar-timing  | APGAR Score Timing | active | 2024-10 | us | hl7 | sct loinc |
hl7.fhir.us.bfdr | R4 | ValueSet-birth-and-fetal-death-financial-class  | Birth and Fetal Death Financial Class | active | 2024-10 | us | hl7 | |
hl7.fhir.us.bfdr | R4 | ValueSet-birth-attendant-titles  | Birth Attendants Titles | active | 2024-10 | us | hl7 | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-birth-delivery-occurred  | Birth Delivery Occurred | active | 2024-10 | us | hl7 | fhir sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-birth-weight-edit-flags  | Birth Weight Edit Flags (NCHS) | active | 2024-10 | us | hl7 | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-delivery-routes  | Delivery Routes | active | 2024-10 | us | hl7 | sct |
hl7.fhir.us.bfdr | R4 | ValueSet-estimate-of-gestation-edit-flags  | Estimate of Gestation Edit Flags (NCHS) | active | 2024-10 | us | hl7 | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-fertility-enhancing-drug-therapy-artificial-insem  | Fertility Enhancing Drug Therapy and Artificial Insemination Value Set | active | 2024-10 | us | hl7 | sct |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-death-cause-or-condition  | Fetal Death Cause or Condition | active | 2024-10 | us | hl7 | fhir sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-death-time-points  | Fetal Death Time Points | active | 2024-10 | us | hl7 | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-presentations-max  | Fetal Presentations - Max | active | 2024-10 | us | hl7 | fhir sct |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-presentations  | Fetal Presentations | active | 2024-10 | us | hl7 | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-remains-disposition-method  | Fetal Remains Disposition Method | active | 2024-10 | us | hl7 | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-infections-during-pregnancy-live-birth  | Infections During Pregnancy Live Birth | active | 2024-10 | us | hl7 | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-informant-relationship-to-mother  | Informant Relationship to Mother | active | 2024-10 | us | hl7 | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-location-types  | Location Types | active | 2024-10 | us | hl7 | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-newborn-congenital-anomalies  | Newborn Congenital Anomalies | active | 2024-10 | us | hl7 | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-number-previous-cesareans-edit-flags  | Number of Previous Cesareans Edit Flags (NCHS) | active | 2024-10 | us | hl7 | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-obstetric-procedure-outcome  | Obstetric Procedure Outcome | active | 2024-10 | us | hl7 | sct |
hl7.fhir.us.bfdr | R4 | ValueSet-performed-not-performed-planned  | Performed NotPerformed Planned | active | 2024-10 | us | hl7 | sct |
hl7.fhir.us.bfdr | R4 | ValueSet-pregnancy-report-edit-flags  | Pregnancy Report Edit Flags (NCHS) | active | 2024-10 | us | hl7 | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-units-of-gestational-age  | Units of Gestational Age | active | 2024-10 | us | hl7 | ucum |
hl7.fhir.us.bfdr | R4 | cigarette-smoking-before-during-pregnancy  | Cigarette Smoking Before and During Pregnancy | active | 2024-10 | us | hl7 | loinc |
ee.fhir.ts | R5 | propertiesvs  | Concept Properties | draft | 2024-10 | ee | | internal fhir |
ee.fhir.ts | R5 | terminology-identifier-type  | Identifier type for terminology assets | draft | 2024-10 | ee | | internal |
hl7.fhir.uv.ichom-breast-cancer | R4 | AgreementResponseVS  | Agreement response ValueSet | active | 2023-08 | uv | hl7 | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | AxillaSurgeryVS  | Axilla surgery ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | BodyWeightVS  | Units of patient's body weight ValueSet | active | 2023-08 | uv | hl7 | ucum |
hl7.fhir.uv.ichom-breast-cancer | R4 | BreastSurgeryTypeVS  | Types of breast surgery ValueSet | active | 2023-08 | uv | hl7 | fhir tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ChemoTherapyTypeVS  | Type of chemotherapy ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ComplicationImpactVS  | Impact of complication ValueSet | active | 2023-08 | uv | hl7 | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ComplicationTypeVS  | Type of complication ValueSet | active | 2023-08 | uv | hl7 | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | EducationLevelVS  | Education level of patient ValueSet | active | 2023-08 | uv | hl7 | sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | EstrogenStatusVS  | Estrogen receptor status ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | GermlineMutationVS  | Germline Mutation ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | GradingVS  | Grading of tumor ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | HER2ReceptorStatusVS  | HER2 receptor status ValueSet | active | 2023-08 | uv | hl7 | sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | HistologicalTypeVS  | Histological type of the tumor ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | HormonalTherapyTypeVS  | Type of hormonal therapy ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ImplantLocationVS  | Location of the implant ValueSet | active | 2023-08 | uv | hl7 | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | InvolvedMarginsReoperationTypeVS  | Re-operation due to involved margins ValueSet | active | 2023-08 | uv | hl7 | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | LateralityNewCancerVS  | Laterality of new cancer ValueSet | active | 2023-08 | uv | hl7 | sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | LateralityVS  | Laterality of breast cancer ValueSet | active | 2023-08 | uv | hl7 | sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | LocationRadiotherapyVS  | The location of radiotherapy ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | MenopausalStatusVS  | Menopausal status of patient ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | MolecularProfilingStatusVS  | Molecular profiling | active | 2023-08 | uv | hl7 | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | NoYesUnknownVS  | Yes, No and Unknown Valueset | active | 2023-08 | uv | hl7 | tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | PatientEducationVS  | Patient Treatment Education ValueSet | active | 2023-08 | uv | hl7 | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | PatientTreatPrefVS  | Patient treatment preference ValueSet | active | 2023-08 | uv | hl7 | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ProgesteroneStatusVS  | Progesterone receptor status ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | RecommendedTreatmentTypeVS  | Recommended treatment types ValueSet | active | 2023-08 | uv | hl7 | fhir sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | ReconstructionTypeVS  | Type of reconstruction surgery ValueSet | active | 2023-08 | uv | hl7 | fhir tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | RecurrenceMethodVS  | Recurrence method ValueSet | active | 2023-08 | uv | hl7 | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | RecurrenceVS  | Recurrence of neoplasm ValueSet | active | 2023-08 | uv | hl7 | fhir tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | RelationshipStatusVS  | Relationship status of patient ValueSet | active | 2023-08 | uv | hl7 | tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ReoperationReasonVS  | Reasoncode of the re-operation | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ReoperationTypeVS  | Type of re-operation | active | 2023-08 | uv | hl7 | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | SACQPatientComorbidityHistory  | SACQ Patient's comorbidity history ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | SatisfactionResponseVS  | Satisfaction response ValueSet | active | 2023-08 | uv | hl7 | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | TNMDistantMetastasesVS  | TNM Distant Metastases ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TNMPrimaryTumorVS  | TNM Primary Tumor ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TNMRegionalNodesVS  | TNM Regional Nodes ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TNMStageGroupVS  | Staging Type for Stage Group ValueSet | active | 2023-08 | uv | hl7 | loinc |
hl7.fhir.uv.ichom-breast-cancer | R4 | TargetedAxillaSurgeryVS  | Targeted axilla surgery ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TargetedTherapyVS  | Type of targeted therapy ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TherapyIntentVS  | Intent of therapy ValueSet | active | 2023-08 | uv | hl7 | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TreatmentPlanComplianceVS  | Observation identifiers for treatment plan non-compliance reason ValueSet | active | 2023-08 | uv | hl7 | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | TreatmentPlanFollowedVS  | Real Treatment Plan Followed ValueSet | active | 2023-08 | uv | hl7 | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | TreatmentPlanNotFollowedVS  | Treatment Plan Not Followed ValueSet | active | 2023-08 | uv | hl7 | fhir tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TreatmentTypeVS  | Type of treatments ValueSet | active | 2023-08 | uv | hl7 | fhir sct tho |
ihe.formatcode.fhir | R4 | http://ihe.net/fhir/ihe.formatcode.fhir/ValueSet/formatcode  | IHE ValueSet of Format Codes for use with Document Sharing | active | 2022-08 | uv | ihe | ihe tho dcm ietf |
ch.fhir.ig.ch-epr-fhir | R4 | ChPdqmMoreAttriburesRequested  | CH PDQm ValueSet More Attributes Requested | active | 2024-12 | ch | hl7 | oid |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmActorIdentifierType  | CH PPQm Actor Identifier Type | active | 2024-12 | ch | hl7 | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmConsentIdentifierType  | CH PPQm Consent Identifier Type | active | 2024-12 | ch | hl7 | internal |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmFeedRequestHttpMethod  | CH PPQm Feed Request HTTP Method | active | 2024-12 | ch | hl7 | fhir |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmPolicySetTemplateId  | CH PPQm Policy Set Template ID | active | 2024-12 | ch | hl7 | internal |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetDefaultProvide  | CH PPQm Referenced Policy Set for Default Provide (203) template | active | 2024-12 | ch | hl7 | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetFullAccess  | CH PPQm Referenced Policy Set for Patients (201) and Representative (303) templates | active | 2024-12 | ch | hl7 | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetGroupEmergency  | CH PPQm Referenced Policy Set for Emergency Access (202) and HCP Group (302) templates | active | 2024-12 | ch | hl7 | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetHcpWithDelegation  | CH PPQm Referenced Policy Set for Healthcare Professionals with Delegation (304) template | active | 2024-12 | ch | hl7 | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetHcpWithoutDelegation  | CH PPQm Referenced Policy Set for Healthcare Professionals without Delegation (301) template | active | 2024-12 | ch | hl7 | ietf |
hl7.fhir.us.qicore | R4 | qicore-medication-dose-type  | QICore SNOMED CT Dosage Codes | draft | 2018-08 | us | hl7 | sct |
hl7.fhir.us.qicore | R4 | qicore-negation-reason  | QICore Negation Reason Codes | active | 2018-12 | us | hl7 | vsac |
hl7.fhir.us.qicore | R4 | qicore-observation-body-position  | QICore Observation Body Position | active | 2018-08 | us | hl7 | sct |
hl7.fhir.us.qicore | R4 | qicore-positive-event-status  | Positive Event Status | active | 2018-12 | us | hl7 | fhir |
hl7.fhir.us.qicore | R4 | qicore-positive-medication-admin-status  | Positive MedicationAdministration Status | active | 2018-12 | us | hl7 | tho |
hl7.fhir.us.qicore | R4 | qicore-positive-medicationdispense-status  | Positive MedicationDispense Status | active | 2018-12 | us | hl7 | tho |
hl7.fhir.us.qicore | R4 | qicore-positive-medicationrequest-status  | Positive MedicationRequest Status | active | 2018-12 | us | hl7 | tho |
hl7.fhir.us.qicore | R4 | qicore-positive-request-status  | Positive Request Status | active | 2018-12 | us | hl7 | fhir |
hl7.fhir.us.qicore | R4 | qicore-positive-task-status  | Positive Task Status | active | 2018-12 | us | hl7 | fhir |
hl7.fhir.us.qicore | R4 | qicore-present-on-admission  | QICore Present On Admission Codes | draft | 2021-05 | us | hl7 | cms |
hl7.fhir.us.insurance-card | R4 | C4DICContactTypeVS  | C4DIC Contact Type | active | 2024-04 | us | hl7 | fhir tho |
hl7.fhir.us.insurance-card | R4 | C4DICCopayTypeVS  | C4DIC Copay Type | active | 2024-04 | us | hl7 | fhir |
hl7.fhir.us.insurance-card | R4 | C4DICCoverageClassVS  | C4DIC Coverage Class | active | 2024-04 | us | hl7 | fhir tho |
hl7.fhir.us.insurance-card | R4 | C4DICCoverageIdentifierType  | C4DIC Coverage Identifier Type | active | 2024-04 | us | hl7 | fhir tho |
hl7.fhir.us.insurance-card | R4 | ISOColorVS  | C4DIC ISO Color | active | 2024-04 | us | hl7 | tho |
hl7.fhir.us.pq-cmc-fda | R5 | capsule-classification-category  | Capsule Shell Classification Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | cmc-comp-section-types-vs  | eCTD sections Terminology | active | 2024-12 | us | hl7 | tho |
hl7.fhir.us.pq-cmc-fda | R5 | cmc-product-name-types-vs  | Product Name Types Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | cmc-specification-types-vs  | Specification Section Type Terminology | active | 2024-12 | us | hl7 | tho |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-analytical-instrument-data-types  | Analytical Instrument Data File Types | active | 2024-12 | us | hl7 | ietf |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-batch-utilization-terminology  | Batch utilization Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-chemical-structure-datafile-type-terminology  | Chemical Structure Data File Type Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-closure-type-terminology  | Closure Type Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-coating-purpose  | Coating Purpose Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-container-type-terminology  | Container Type Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-drug-product-component-function-category-terminology  | Drug Product Component Function Category Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-excipient-function-terminology  | Excipient Function Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-genc-and-iso-intersect  | GENC and ISO 3166 Intersection | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-graphical-file-types  | Graphical File Types | active | 2024-12 | us | hl7 | ietf |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-impurity-classification-terminology  | Impurity Classification Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-manufactured-dose-form-terminology  | Manufactured Dose Form Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-name-part-terminology  | PQCMC Name Part Terminology | active | 2024-12 | us | hl7 | tho |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-non-percentage-units  | Non-Percentage Units | active | 2024-12 | us | hl7 | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-org-identifier-type-terminology  | Organization-Site Identifier Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-percentage-units  | Percentage Units | active | 2024-12 | us | hl7 | ucum |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-product-part-ingredient-physical-location  | Ingredient Location Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-product-part-type  | Product Part Type Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-quality-benchmark-terminology  | Quality Benchmark Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-release-mechanism  | Release Mechanism Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-release-profile  | Release Profile Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-representation-types  | Representation Types | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-source-type-terminology  | Source Type Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-status-terminology  | Specification Status Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-type-terminology  | Specification Type Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-strength-type-terminology  | Strength Type Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-structure-data-types  | Structure Data Types | active | 2024-12 | us | hl7 | ietf |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-substance-name-type  | Substance Name Type | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-category-terminology  | Test Category Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-method-origin-terminology  | Test Method Origin Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-usage-terminology  | Test Usage Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-units-of-measure  | Units Of Measure | active | 2024-12 | us | hl7 | ucum |
hl7.fhir.us.pq-cmc-fda | R5 | spl-drug-route-of-administration-terminology  | Drug Route Of Administration Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | spl-pharmaceutical-dosage-form-terminology  | Pharmaceutical Dosage Form Terminology | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | substance-classification  | Substance Classification | active | 2024-12 | us | hl7 | ncit |
hl7.fhir.pt.obs-neonat | R4 | bulletin-delivery-vs  | Envio de boletim ValueSet | active | 2024-12 | pt | hl7 | internal |
hl7.fhir.pt.obs-neonat | R4 | document-type-vs  | Tipo de documento ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.pt.obs-neonat | R4 | episode-type-vs  | Tipos de episódio ValueSet | active | 2024-12 | pt | hl7 | internal |
hl7.fhir.pt.obs-neonat | R4 | newborn-congenital-anomalies-vs  | Tipos de doença congénita ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.pt.obs-neonat | R4 | newbornriskassessment-vs  | Tipos de risco para avaliação de recém-nascidos ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.pt.obs-neonat | R4 | puerperium-vs  | Tipos de outcome de puerpério ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.pt.obs-neonat | R4 | risco-gravidez-vs  | Risco de gravidez ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.pt.obs-neonat | R4 | tipo-gravidez-vs  | Tipo de gravidez ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.pt.obs-neonat | R4 | tipo-parto-vs  | Tipos de parto ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.pt.obs-neonat | R4 | transport-type-vs  | Tipos de transporte de recém-nascido ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.pt.obs-neonat | R4 | vacinas-infancia-vs  | Vacinas ValueSet | active | 2024-12 | pt | hl7 | sct |
hl7.fhir.us.davinci-atr | R4 | atr-attribution-list-status  | DaVinci Attribution List Status | active | 2020-09 | us | hl7 | fhir |
hl7.fhir.us.davinci-atr | R4 | atr-changetype  | DaVinci ATR Change Types | active | 2020-09 | us | hl7 | fhir |
hl7.fhir.us.davinci-atr | R4 | davinci-group-characteristic  | DaVinci Group Characteristic | active | 2020-09 | us | hl7 | fhir |
fhir.cqf.common | R4 | active-condition  | CQF Active Condition | active | 2019-07 | us | hl7 | tho |
fhir.cqf.common | R4 | inactive-condition  | CQF Inactive Condition | active | 2019-07 | us | hl7 | tho |
hl7.fhir.uv.fhir-for-fair | R4B | related-artifact-type  | RelatedArtifactType [ValueSet] | active | 2024-01 | uv | hl7 | fhir |
hl7.fhir.us.core | R4 | detailed-ethnicity  | Detailed ethnicity | active | 2022-09 | us | hl7 | vsac |
hl7.fhir.us.core | R4 | detailed-race  | Detailed Race | active | 2022-09 | us | hl7 | vsac |
hl7.fhir.us.core | R4 | omb-ethnicity-category  | OMB Ethnicity Categories | active | 2022-09 | us | hl7 | vsac |
hl7.fhir.us.core | R4 | omb-race-category  | OMB Race Categories | active | 2022-09 | us | hl7 | vsac |
hl7.fhir.us.core | R4 | simple-language  | Language codes with language and optionally a region modifier | active | 2022-09 | us | hl7 | ietf |
hl7.fhir.us.core | R4 | us-core-clinical-note-type  | US Core Clinical Note Type | active | 2024-05 | us | hl7 | loinc |
hl7.fhir.us.core | R4 | us-core-clinical-result-observation-category  | US Core Clinical Result Observation Category | active | 2023-04 | us | hl7 | tho |
hl7.fhir.us.core | R4 | us-core-condition-code  | US Core Condition Codes | active | 2022-09 | us | hl7 | sct tho icd |
hl7.fhir.us.core | R4 | us-core-diagnosticreport-category  | US Core Diagnostic Report Category Codes | active | 2022-09 | us | hl7 | loinc |
hl7.fhir.us.core | R4 | us-core-diagnosticreport-report-and-note-codes  | US Core Non Laboratory Codes | active | 2022-09 | us | hl7 | loinc |
hl7.fhir.us.core | R4 | us-core-documentreference-category  | US Core DocumentReference Category | active | 2022-09 | us | hl7 | fhir |
hl7.fhir.us.core | R4 | us-core-documentreference-type  | US Core DocumentReference Type | active | 2022-09 | us | hl7 | tho loinc |
hl7.fhir.us.core | R4 | us-core-goal-description  | US Core Goal Codes | active | 2022-09 | us | hl7 | sct loinc |
hl7.fhir.us.core | R4 | us-core-laboratory-test-codes  | US Core Laboratory Test Codes | active | 2022-11 | us | hl7 | loinc |
hl7.fhir.us.core | R4 | us-core-location-type  | US Core Location Type | active | 2024-10 | us | hl7 | tho |
hl7.fhir.us.core | R4 | us-core-narrative-status  | US Core Narrative Status | active | 2022-09 | us | hl7 | fhir |
hl7.fhir.us.core | R4 | us-core-observation-smoking-status-status  | US Core Status for Smoking Status Observation | active | 2022-09 | us | hl7 | fhir |
hl7.fhir.us.core | R4 | us-core-problem-or-health-concern  | US Core Problem or Health Concern | active | 2022-09 | us | hl7 | fhir tho |
hl7.fhir.us.core | R4 | us-core-procedure-code  | US Core Procedure Codes | active | 2022-09 | us | hl7 | sct cpt cms loinc |
hl7.fhir.us.core | R4 | us-core-provenance-participant-type  | US Core Provenance Participant Type Codes | active | 2022-09 | us | hl7 | fhir tho |
hl7.fhir.us.core | R4 | us-core-screening-assessment-condition-category  | US Core Screening Assessment Condition Category | active | 2024-11 | us | hl7 | fhir |
hl7.fhir.us.core | R4 | us-core-screening-assessment-observation-category  | US Core Screening Assessment Observation Category | active | 2024-11 | us | hl7 | fhir tho |
hl7.fhir.us.core | R4 | us-core-screening-assessment-observation-maximum-category  | US Core Screening Assessment Observation Maximum Category | active | 2024-11 | us | hl7 | fhir tho |
hl7.fhir.us.core | R4 | us-core-servicerequest-category  | US Core ServiceRequest Category Codes | active | 2022-09 | us | hl7 | fhir sct |
hl7.fhir.us.core | R4 | us-core-simple-observation-category  | US Core Simple Observation Category | active | 2024-11 | us | hl7 | fhir tho |
hl7.fhir.us.core | R4 | us-core-specimen-condition  | US Core Specimen Condition | active | 2024-11 | us | hl7 | vsac tho |
hl7.fhir.us.core | R4 | us-core-usps-state  | USPS Two Letter Alphabetic Codes | active | 2022-09 | us | hl7 | |
hl7.fhir.us.mihr | R4 | PregnancyNonLive  | Pregnancy Non-Live | draft | 2023-03 | us | hl7 | vsac |
hl7.fhir.us.mihr | R4 | PregnancyProcedureDelivery-CPT  | Pregnancy Procedure Delivery CPT | draft | 2023-03 | us | hl7 | cpt |
hl7.fhir.us.mihr | R4 | PregnancyProcedureDelivery  | Pregnancy Procedure Delivery | draft | 2023-03 | us | hl7 | fhir vsac |
hl7.fhir.us.mihr | R4 | hypertensive-disorders-pregnancy-ICD  | ValueSet – Hypertensive Disorders of Pregnancy ICD | draft | 2023-03 | us | hl7 | icd |
hl7.fhir.us.mihr | R4 | hypertensive-disorders-pregnancy-SNOMED  | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT | draft | 2023-03 | us | hl7 | sct |
hl7.fhir.us.mihr | R4 | hypertensive-disorders-pregnancy |